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ABSTRACT 
 Sertoli cells are the only somatic cell type present within the seminiferous tubules of the 
testis. The support of these somatic cells is essential for testis formation and spermatogenesis. 
They are called mother or nurse cells, implicating their intimate association with germ cells and 
also their central role in germ cell development. In mice, at embryonic day 11 (E11), Sertoli cells 
start to proliferate and continue to proliferate until two weeks postnatal. Puberty involves 
cessation of mitosis and progression of maturation/differentiation in Sertoli cells. Although 
Sertoli cell development has been extensively studied using various animal models, it is not yet 
fully understood. Thyroid hormone (T3) is a critical regulator of Sertoli cell development. Later 
studies identified that thyroid hormone effects on Sertoli cell development were mediated by 
some of the cell cycle proteins namely, p27
Kip1
, p21
Cip1
 and SKP2 (also known as CDKN1B, 
CDKN1A and p45, respectively). Roles of these cell cycle regulators on Sertoli cell development 
have been studied and Sertoli cell numbers were significantly altered in the absence of one or 
more of those cell cycle regulators. In addition, some studies suggested a mediatory role of the 
predominant testicular gap junction protein, connexin 43 (CX43), in the thyroid hormone effect 
on Sertoli cell development. To understand the specific role of CX43 in Sertoli cell development, 
I generated an animal model in which Cx43 is specifically deleted in Sertoli cells to circumvent 
the neonatal lethality of the Cx43 global knockout. Results indicated that in the absence of 
CX43, Sertoli cells failed to mature fully and also a significant population of Sertoli cells 
proliferated indefinitely into adulthood. The Sertoli cell phenotype of this animal model is 
unique and distinctly different from other animal models. Further exploration of Sertoli cell 
development was pursued using the Sertoli cell-specific CX43 knockout (SC-Cx43 KO) animal 
model. The first aim was to understand the proliferative pattern of SC-Cx43 KO Sertoli cells in 
vitro and also to determine whether these Sertoli cells respond differently to mitogenic and/or 
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maturation induction stimuli. Results showed that Sertoli cells in this animal model switch 
between the resting and active phases of the cell cycle in vitro. Although Sertoli cells are 
proliferating even beyond the normal proliferative period in SC-Cx43 KO mice, their 
proliferation was unaltered by either mitogenic and/or maturation induction stimuli in vitro. The 
rest of the aims focused on understanding whether some major cell cycle regulators (SKP2, 
p27
Kip1 
and p21
Cip1
), which were already shown to affect Sertoli cell development, were involved 
in the indefinite proliferation in Sertoli cells lacking CX43.  In the second aim, I tested whether 
concomitant deletion of SKP2 in SC-Cx43 KO mice will stop the proliferation of Sertoli cells 
observed in SC-Cx43 KO mice. The results showed that Sertoli cell proliferation is stopped in 
SC-Cx43 KO Sertoli cells when they also lack SKP2. In the third aim, I tested whether the 
concomitant deletion of either p27
Kip1
 or p21
Cip1
 in the SC-Cx43 KO mice will potentiate the 
proliferation of Sertoli cells noticed in SC-Cx43 KO mice. The results showed that the 
proliferation of Sertoli cells was not potentiated by knocking out either p27
Kip1
 or p21
Cip1
 in SC-
Cx43 KO mice. However, Sertoli cell proliferation is persistent but significantly lower than SC-
Cx43 KO mice when either p27
Kip1
 or p21
Cip1
 is deleted in SC-Cx43 KO mice. The collective 
findings of the present study provide important insights into the role of CX43 in Sertoli cell 
maturation and also the factors involved in the mechanism by which CX43 regulates Sertoli cell 
proliferation. 
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INTRODUCTION 
  Sertoli cells are one of the somatic cell types of the testis. Their support is indispensible 
for germ cell development and overall spermatogenesis. Terminal differentiation and cessation of 
Sertoli cell mitogenesis occur by two weeks of age in mouse Sertoli cells and they then acquire the 
capacity to perform their specialized function of supporting spermatogenesis. Once Sertoli cell 
proliferation stops, the adult population is established and no further mitogenesis occurs. Also, 
once Sertoli cells are damaged they cannot be repaired or regenerated. Sertoli cell number 
determines the efficiency of sperm production because each Sertoli cell supports a fixed number of 
germ cells. Even though Sertoli cell development has been studied extensively, the mechanism 
responsible for the transition of Sertoli cells from the proliferative to differentiative phase is not 
well understood. It is essential to understand the mechanisms regulating Sertoli cell development 
to resolve infertility problems that are related to Sertoli cell development.  
 The major endocrine regulators of Sertoli cell development are follicle stimulating 
hormone (FSH) and thyroid hormone (T3). Neonatal Sertoli cell cultures treated with FSH showed 
more proliferation. On the other hand, T3 treatment induced maturational events in neonatal Sertoli 
cells in vitro. The role of T3 on Sertoli cell development has been studied extensively by various 
laboratories, including ours. Previous studies have shown that cyclin dependent kinase inhibitors 
(CDKIs) like p27
Kip1 
and p21
Cip1 
play major roles in determining the Sertoli cell number in mice. 
Additionally, an F-box protein, SKP2 (S-Phase kinase protein), which is the major regulator of 
p27
Kip1 
concentrations in a cell, also plays a role in regulating Sertoli cell development. Previous 
studies identified that p27
Kip1 
and p21
Cip1
, and possibly SKP2, are involved in the thyroid hormone 
effect on Sertoli cell development in mice. 
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  Sertoli cells communicate among themselves and with germ cells through gap junctions. 
It has been suggested that these gap junctions in testis, and especially the most abundant testicular 
gap-junction protein, connexin 43 (CX43, also known as GJA1), play crucial roles in the 
development and maturation of spermatozoa [1]. Despite extensive studies in vivo and in vitro 
suggesting that CX43 may be critical for various facets of spermatogenesis and Sertoli cell 
function
 
[2-15], the role of CX43 in the Sertoli cell has not been definitively established. To 
understand the specific role of CX43 in Sertoli cell development, a Sertoli cell-specific Cx43 
knockout (SC-Cx43 KO) mouse was generated using Cre-lox technology. In chapter II, the role of 
CX43 in mouse Sertoli cells was discussed. Results showed that there is a significant population of 
Sertoli cells proliferating even beyond the normal proliferative period in SC-Cx43 KO mice. This 
indicates that lack of CX43 in Sertoli cells inhibited complete maturation of Sertoli cells due to 
indefinite extension of their proliferative period. This study showed that CX43 plays key roles in 
Sertoli cell development.  
 Several studies had shown that Sertoli cells from adult mice are non-proliferative and 
unresponsive to either mitogenic or maturational induction stimuli. However, in SC-Cx43 KO 
mice, we observed proliferation of adult Sertoli cells in vivo as well as in vitro, which leads to the 
question of whether this extended proliferation would allow adult Sertoli cells of SC-Cx43 KO 
mice to respond to mitogenic and maturation induction stimuli. Also, it is unknown whether CX43 
in Sertoli cells affects the mitogenic effect of FSH hormone on neonatal Sertoli cells. Previous 
studies identified CX43 as a mediator of T3 effect on Sertoli cell proliferation. Nevertheless, it is 
also unknown whether CX43 is the sole mediator of the T3 effect on Sertoli cell development. 
Therefore, In Chapter III, I tested whether adult SC-Cx43 KO Sertoli cells are responsive to FSH 
and/or T3 treatment in terms of Sertoli cell proliferation. We tested this by assessing percent 
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proliferation of FSH and/or T3 treated adult SC-Cx43 KO Sertoli cells in comparison to that of 
untreated age-matched Sertoli cells of the same genotype. Our results showed that SC-Cx43 KO 
Sertoli cells at 20 and 60 days did not respond to either of these hormones. These results indicated 
that despite the proliferation in a significant population of Sertoli cells in SC-Cx43 KO mice, the 
proliferation is not enhanced/decreased by FSH/T3 hormones, respectively, suggesting that 
systemic hormones are not involved in the proliferation of Sertoli cells in the absence of CX43.  
  From an extensive body of literature, it is known that Sertoli cell development is 
modulated by cell cycle regulators. It is unknown, in the SC-Cx43 KO mice, whether the 
proliferation of Sertoli cells can be manipulated by modulation of some of the cell cycle regulators, 
which were already shown to play a role in Sertoli cell development. In Chapters IV and V, we 
tested the involvement of cell cycle regulators (SKP2 in chapter IV; p27
Kip1 
and p21
Cip1 
in chapter 
V) in the CX43 effect on Sertoli cell development. We generated double knockout (DBKO) animal 
models, namely Skp2/SC-Cx43, p27/SC-Cx43 and p21/SC-Cx43 to test the involvement of SKP2, 
p27
Kip1 
and p21
Cip1
, respectively, in the CX43 effect on Sertoli cell proliferation. Our results 
showed that lack of SKP2 along with CX43 in Sertoli cells shut down the extended proliferation 
noticed in SC-Cx43 KO Sertoli cells. This resulted in decreased Sertoli cell number (as observed in 
Skp2 KO) in Skp2/SC-Cx43 DBKO when compared to SC-Cx43 KO mice. On the other hand, 
p27
Kip1 
or p21
Cip1 
deletion along with CX43 in Sertoli cells did not further increase the Sertoli cell 
proliferation noticed in SC-Cx43 KO mice as expected. However, Sertoli cell numbers of p27/SC-
Cx43 and p21/SC-Cx43 DBKOs were comparable to p27 or p21 KOs, respectively. 
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CHAPTER I 
REVIEW OF LITERATURE 
Sertoli cells and their development 
  Sertoli cells were discovered by Enrico Sertoli in1865. He called them mother cells, 
which implicated their indispensible role in the testis. Sertoli cells are the first cell type to 
differentiate in the testis [16, 17]. Sertoli cells play a pivotal role in directing testis development, as 
they express Sry (sex-determining region on the Y chromosome) and Amh (anti-Mullerian 
hormone) genes, which are essential for sex determination and regression of female reproductive 
tract structures, respectively [18, 19]. In mice, Sertoli cells originate from coelomic epithelium at 
E11.2 to E11.4 and this event occurs only during a narrow window of development [17, 20]. 
However, some studies have suggested mesonephric cells as a possible source of Sertoli cells [21-
23]. Neither mesonephros nor coelomic epithelium give rise to Sertoli cells after E11.5 because 
testis cords start to develop and the cell migration into the gonad is gradually terminated [17, 24]. 
The primordium for Sertoli cells is still controversial. Also, the development of Sertoli cells is not 
fully understood. 
  Sertoli cell development is comprised of two phases: proliferation and differentiation. In 
rodents, Sertoli cells begin to proliferate during the fetal period and this mitotic activity is reduced 
by 15-21 days of age, which coincides with a marked increase in differentiation [25-28]. The 
differentiation phase results in a dramatic change in morphology and function of these cells. In 
humans, monkeys, bulls and pigs the Sertoli cell proliferation takes place in two phases with a 
quiescent stage in between those two phases [29].  During the onset of puberty Sertoli cells 
undergo differentiation. Once proliferation ceases and differentiation is complete, Sertoli cells 
never revert back to proliferation under normal conditions.  
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Role of endocrine regulators in Sertoli cell development 
The mechanisms involved in Sertoli cell proliferation and differentiation, as well as the 
transition between these two states, are not fully understood. Various factors such as FSH, 
androgen, and T3 play key roles in Sertoli cell development [30]. FSH was shown to be a major 
regulator of Sertoli cell proliferation using Fsh and Fsh-receptor (Fshr) KOs, which showed 
decreased Sertoli cell number [31, 32], but FSH has no mitogenic effect on juvenile or adult Sertoli 
cells [25, 33]. The FSH-R is a cell surface marker of Sertoli cells, which activates diverse 
signalling pathways according to the differentiation stage leading to appropriate cellular responses 
[34-37]. A mitogenic response to FSH has been reported in 5-day-old rat Sertoli cells [38]. At this 
stage, FSH enhances the phosphorylation of MAP kinases, ERK1 and ERK2, which in turn 
increases cyclin D1 expression. In contrast, FSH totally switches off the ERK pathway in 19-day-
old rat Sertoli cells, and in vitro, cell proliferation becomes insensitive to FSH [34]. Recently, it 
has been shown that FSH enhances the protein level of PTEN (phosphatase and tensin homolog 
deleted in chromosome 10), which dephosphorylates PIP3 (phosphoinositide (3,4,5) P3) and thus 
antagonizes PI3K (phosphoinositide-3 kinase) activity in differentiating rat Sertoli cells. Moreover, 
PTEN level is not altered by FSH exposure of proliferating rat Sertoli cells [39]. 
In Sertoli cell-specific androgen receptor knockout mice, Sertoli cell numbers were 
comparable with that of age matched wt mice [40]. However, mice lacking a functional androgen 
receptor (Tfm) or treated with an anti-androgen have reduced adult Sertoli cell numbers [41, 42].  
In male rats, T3 levels increase between 3 and 10d and reach adult levels by 15d [33]. T3 
effects on Sertoli cell development have been studied extensively by many laboratories including 
ours. Also, it has been known for nearly six decades that neonatal hypothyroidism retards 
maturation and onset of spermatogenesis [43]. Recently, it was shown that propylthiouracil-induced 
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neonatal hypothyroidism in rats leads to accumulation of insoluble hyperphosphorylated vimentin 
which in turn results in loss of cytoskeletal integrity in Sertoli cells [44]. T3 regulates the duration 
of proliferation in Sertoli cells. A direct effect of T3 was shown by treating Sertoli cells with T3, 
which led to termination of Sertoli cell proliferation and induction of Sertoli cell maturation [38, 45, 
46]. In addition, the mediators of T3 effects on Sertoli cells were identified as thyroid hormone 
receptor alpha 1 (TR 1) [47, 48], and other cell cycle regulators namely, p27
Kip1
,
 
p21
Cip1 
[49] and 
SKP2 (Oki, unpublished data).  
Role of cell cycle regulators in Sertoli cell development 
As in all other eukaryotic cells, proliferation of Sertoli cells is dependent upon progression 
through the cell cycle. Cell cycle proteins and ubiquitin ligases are crucial for the proper regulation 
of cell progression through each phase of the cell cycle. Cell cycle progression is controlled by 
cyclins, cyclin-dependent kinases (CDKs), and CDKIs. The complex of cyclins and CDKs drives 
the cell cycle forward. Cyclins and CDKs are regulated by CDKIs, including p27
Kip1 
and p21
Cip1
. 
CDKIs prevent cell cycle progression by binding to and deactivating the cyclins and CDKs in the 
G1 to S phase transition of the cell cycle [50, 51].  
p27
Kip1
, a CDKI, is not regulated at the level of transcription, but instead is regulated post-
translationally, mainly by a ubiquitin-ligase called SKP2, which targets p27
Kip1
 for ubiquitination 
and subsequent degradation by the 26S proteasome. The level of p21
Cip1
 expression is regulated by 
ubiquitin-dependent as well as ubiquitin-independent mechanisms. During proliferation, the level of 
SKP2 expression is highest in the S and the G2 phases of the cell cycle, thus maintaining low levels 
of p27
Kip1 
and allowing the cell to continue through the cell cycle. As the cell exits the cell cycle, 
SKP2 levels decrease and in turn p27
Kip1 
concentration increases. Of note, it has been shown that 
poorly differentiating embryoid bodies of human embryonic stem cells exhibited low p27
Kip1
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expression and a high Skp2/p27
Kip1
 ratio [52], indicating that the negative correlation between 
p27
Kip1 
and SKP2 expression is applicable even to human stem cells.  
Expression of p27
Kip1
 is maximal in adult Sertoli cells and corresponds with Sertoli cell 
maturation [53, 54]. It has been demonstrated that p27
Kip1 
and p21
Cip1 
have a negative influence on 
Sertoli cell proliferation. Also, lack of p27
Kip1 
or both p27
Kip1 
and p21
Cip1 
resulted in a permanent 
increase in adult Sertoli cell numbers in p27 KO, p21 KO and p27/p21 DBKO mice [49]. Though 
p21
Cip1
 is important in controlling Sertoli cell proliferation, its role appears to be secondary to that 
of p27
Kip1 
because the increase in Sertoli cell number in p27 KOs was 150% greater than that of p21 
KOs. In addition p27/p21 DBKOs did not show any further increase in Sertoli cell number when 
compared to p27KOs [49]. In contrast to p27 KO,  p21 KO and p27/p21 DBKO mice, there is a 
significant reduction in adult Sertoli cell number in Skp2 KO mice, implicating that SKP2 is also 
playing a critical role in Sertoli cell proliferation (Oki et al, unpublished result). Regulation of 
SKP2 is not well understood. Notch signaling upregulates SKP2, which enhanced proteosme-
mediated degradation of CDKIs, p27
Kip1 
and p21
Cip1 
results in premature entry into S-phase of cell 
cycle. Also, lack of p21
Cip1 
potentiates Notch1 activation to downregulate p27
Kip1 
[55]. 
Terminal differentiation is associated with cell cycle exit in Sertoli cells as observed in 
many other cell types. Hypophosphorylated retinoblastoma (RB) protein is a marker of cell cycle 
exit. CDKIs like p27
Kip1
 inhibit cyclin/cyclin-dependent kinase (CDK) complex formation, which 
results in the sustenance of hypophosphorylated RB. Recently, a study demonstrated that RB is not 
essential for initiation of differentiation but is essential for sustenance of the terminal differentiation 
in Sertoli cells using Sertoli cell-specific Rb KO animal model [56]. In the absence of RB in Sertoli 
cells, testis weights, germ cell maturation and fertility were normal up to 6 weeks of age. However, 
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by 8 weeks of age, Sertoli cell dysfunction is evident by reduction in testis weight, loss of germ 
cells and infertility. 
Another important cell cycle regulator which has been extensively studied are ID (inhibitors 
of differentiation/DNA binding) proteins. An early study demonstrated that individual 
overexpression of Id1 and Id2 genes in terminally differentiated rat Sertoli cells in vitro reinitiated 
mitosis in these nonmitogenic cells and allowed them to remain proliferative indefinitely [57, 58]. 
Also, ID proteins bind to and inactivate RB protein. Id1 regulates keratinocyte replication via 
inhibition of p16 [57], which in turn increases phosphorylated form of RB [59]. Id2 gene also 
disrupts the anti-proliferative effects of RB and allows cell cycle progression [60].  
Differentiation markers of Sertoli cells 
Differentiation of Sertoli cells involves loss of proliferation and acquisition of the capability to 
support spermatogenesis. Protein markers expressed by Sertoli cells provide a better understanding 
of their maturation status. Some of the markers are AMH, TR 1, aromatase, androgen receptor, 
clusterin, GATA1, WT1 (Wilm‟s tumor 1) antigen and cytokeratin-18. 
Persistence of AMH expression indicates immaturity of Sertoli cells [61, 62]. Neonatal 
hypothyroidism prolongs expression of AMH and TR 1 and also delays the expression of androgen 
binding protein and clusterin by Sertoli cells and results in prolongation of their proliferative phase 
[63].  
Neonatal Sertoli cells express aromatase, which mediates biosynthesis of estrogen from 
androgen, and this activity decreases around puberty leading to decrease in expression of aromatase 
by mature Sertoli cells. T3 treatment inhibits aromatase activity in neonatal Sertoli cells in vitro 
[64] and stimulates androgen receptor expression in cultured Sertoli cells [65]. The rise in FSH and 
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testosterone concentrations at puberty coincides with an increase in androgen receptor expression in 
Sertoli cells [29].  
WT1, a stable marker of Sertoli cells, is a transcription factor, whose expression is turned on 
during the fetal stage [66]. WT1 expression is unaltered in immature rat Sertoli cells, which fail to 
express p27
Kip1 
[29]. Cytokeratin-18, an epithelial cell marker, is expressed in immature or de-
differentiated Sertoli cells [15, 67]. GATA-1, which is also a transcription factor, starts to be 
expressed  in Sertoli cells during the first wave of spermatogenesis [68]. In Sertoli cells, AMH and 
GATA-1 expressions are inversely related [69].  
Junctional complexes in testis 
In the seminiferous epithelium of the testis, there are three types of intercellular junctions: 
cadherin-based adherens junctions, occludin-based tight junctions, and connexin-based gap 
junctions. All these junctions interact together to form the blood-testis barrier [70], which 
physically divides the seminiferous epithelium into basal and apical compartments [71].
 
Early stage 
of germ cells (up to pre-leptotene stage) are located in the basal compartment whereas, leptotene 
and other later stages are present in the adluminal compartment [72]. The blood-testis barrier 
protects the non-self spermatids from the vasculature and establishes testicular immune privilege 
[73, 74]. The ectoplasmic specializations and tubulobulbar complexes present basally are the 
adherens junctions between Sertoli cells. Beta-catenin is an adherens junction protein and some 
studies suggested that active beta-catenin signaling is physiologically significant in Sertoli cells. A 
recent study showed that constitutive activation of beta-catenin conditionally in Sertoli cells 
resulted in continuous proliferation of Sertoli cells and expression of markers with high expression 
in immature Sertoli cells. Also nuclear accumulation of beta-catenin in Sertoli cells resulted in 
impaired germ cell development and ultimately depletion of germ cells via apoptosis [75]. 
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Among the junctional complexes, the gap junction is unique because it is the only junction 
that can also serve as a passage for ions and molecules (<1–1.5 kDa) between cells forming the gap 
junctions. This type of intercellular communication has been shown to be involved in cell division, 
growth, and apoptosis in various cell types. Recently it has been identified that gap junctions in 
testis are the potential modulators of other junctions, which emphasize the importance of gap 
junctions in testis [76]. Electron microscopy studies showed that the number of gap junctions is 
higher in the area of blood-testis barrier [77]. Gap junctional communication is reduced during 
stages IX-X of spermatogenesis, which signified its essential role in germ cell development [5]. 
Connexin based gap junctions in testis  
Dym and Fawcett described gap junctions using electron microscopy for the first time in a 
rat testis [78]. In the mature rat testis, eleven different CXs (i.e. CX26, CX30.2, CX31, CX31.1, 
CX32, CX33, CX37, CX40, CX43, CX46 and CX50) have been detected [review [1, 70]]. 
Transcripts for Cx26, Cx30.3, Cx31, Cx31.1, Cx32, Cx37, Cx40, Cx43, Cx45 and Cx46 were 
detected in the fetal mouse testis [9]. It has been suggested that these gap junctions in testis, and 
especially the most abundant testicular gap junction protein, CX43, play crucial roles in the 
development and maturation of spermatozoa [1]. 
Gap junctions have been identified not only in mammals but also in non-mammalian 
species. Sertoli-Sertoli gap junctions in fish were first detected in cartilaginous fish [79]. More 
recently, connexin was first detected in the Sertoli cell cortical cytoplasm of catfish [80]. Fish 
spermatogenesis takes place in cysts and the connexin based gap junctions may possibly be 
essential for synchronous development of germ cells and progression of spermatogenesis [81]. In 
the frog testis, CX43 expression was higher when spermatogenesis is at a maximum level indicating 
that Cx43 plays an important role in frog spermatogenesis [82]. 
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Connexin 43 in mouse testis 
In mice, CX43 is expressed in the undifferentiated gonad at E11.5 between primordial germ 
cells and somatic cells. At E12.5, CX43 was localized between adjacent Sertoli cells and also in cell 
borders between germinal and Sertoli cells in the seminiferous cord [83]. CX43 expression is 
modulated based on the stages of spermatogenesis. Also, the level of CX43 expression was reduced 
in seminiferous tubules of infertile mice mutants, compared to the respective wt mice [2]. Various 
knockout mouse models have demonstrated the importance of CX43 in spermatogenesis. Cx43 
knockout (Cx43 KO) mice were not viable postnatally due to cardiac malformation and the testes 
were hypotrophic because of a severe germ cell deficiency [9]. When testes from Cx43 KO fetuses 
were grafted under the renal capsules of adult males, the seminiferous epithelium showed a Sertoli 
cell-only phenotype with only a few germ cells, which indicated that CX43 is required for postnatal 
germ cell expansion [13].  
The requirement for CX43 is tissue-specific; when Cx43 was replaced with connexin 40 
(Cx40) using a knock-in model, the cardiac malformation responsible for lethality of the global 
knockout was reversed and the animals were viable. However, seminiferous epithelial abnormalities 
seen in Cx43 KO mice persisted in the Cx40 knock in [11], illustrating an essential and non-
redundant role of CX43 in the testis despite the ability of other CXs to effectively substitute for 
CX43 in heart. [6]. Furthermore, CX43 expression was not detected in Sertoli cell-only 
seminiferous tubules in jun-d
-/-
 mice [2]. Recently, absence of CX43 immunoreactivity was reported 
in immature seminiferous tubules (Sertoli cell nodules) and in neoplastic Sertoli cells in human 
[84]. These findings imply that CX43 expression was altered in seminiferous tubules with impaired 
spermatogenesis. Despite extensive studies in vivo and in vitro that suggest that CX43 may be 
critical for various facets of spermatogenesis and Sertoli cell function [4-6, 8, 10, 13], the role of 
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CX43 in the Sertoli cell and the seminiferous epithelium in general has not been definitively 
established. 
 Link between endocrine regulators and connexin 43 
  CX43 expression levels are regulated by steroid hormones in myometrium [85, 86], 
different compartments of the follicle [87], Leydig cells [88], seminiferous tubules [89] and prostate 
gland [90], thus affecting the functions of male and female reproductive systems. There is an 
extensive body of literature that suggested the modulation of CX43 expression by various endocrine 
regulators like estrogen, progesterone, androgens, FSH, LH, and T3 [8, 87, 88, 90].  
   The assembly of CX43 into functional gap junctional plaques is indispensible for 
synchronized myometrial contractions typical of labor in rats [91]. Labor is inhibited in pregnant 
rats treated with either anti-estrogen (ICI 182,780) or progesterone. The mechanisms by which both 
anti-estrogen and progesterone inhibit labor involve CX43. However, anti-estrogen significantly 
reduced CX43 concentrations in the myometrium whereas, progesterone affected assembly of 
CX43 gap junction at the plasma membrane of myometrium without altering CX43 expression 
levels. Recently, it was shown that enhancement of CX43 expression in response to estrogen in 
uterine stromal cells is essential for successful implantation [92].  
  There is strong evidence that hypothalamic CX43 expression is regulated by steroid 
hormones in specific regions of the brain in rodents and also in a sexually dimorphic manner, which 
suggested that modulation of CX43 based gap junctional communication may be a factor regulating 
the estrous cycle and sexual behavior in female rodents [93]. Prostate development is regulated by 
androgens. Following castration, CX43 expression was increased and also resulted in enhanced 
apoptosis. Dihydrotestosterone treatment to castrated rats abolished the increase in CX43 
expression as well as apoptosis [90].   
  
13 
   FSH is a major regulator of follicle development in ovary. Both gap junctional coupling 
and CX43 expression are higher in large antral follicles when compared to small antral and 
preantral follicles. In a rat granulosa cell line, FSH supplementation induced intercellular coupling 
and also increased CX43 expression levels. These changes are associated with reduced proliferation 
and enhanced differentiation of granulosa cells [94]. Lindane, a gap junction blocker suppressed the 
FSH plus TGF-  stimulated progesterone production in ovarian granulosa cells in rats. This 
suggested that CX43 expression is critical for FSH plus TGF-  induced progesterone production in 
rat granulosa cells [95]. LH downregulated CX43 expression in rat ovarian follicles by decreasing 
the rate of CX43 translation and this effect was mediated by both MAPK and PKA signaling 
pathway [87]. 
The CX43 promoter region contains a putative thyroid response element, which interacts 
with thyroid receptor-T3 complex and transactivates gene expression
 
in response to thyroid 
hormone [96, 97]. T3 treatment of cultured cardiomyocytes from neonatal rats showed enhanced 
CX43 expression compared to untreated controls [98]. Cx43 mRNA expression was increased after 
T3 treatment and in diabetes condition. At the same time CX43 phosphorylation was reduced in 
hyperthyroid and diabetes conditions that could impair gap junction coupling in the heart and 
development of atrial tachyarrhythmia in those conditions [99]. Previous studies suggested that 
CX43 mediated the thyroid hormone effect on Sertoli cell development. In rats, CX43 expression is 
exclusively expressed along the plasma membrane of Sertoli cells by 30d. CX43 did not localize to 
the plasma membrane and was still cytoplasmic at 30d in rats treated with propylthiouracil (PTU) 
neonatally, which induced hypothyroid condition. Also, in caput or corpus segments of epididymis 
CX43 was undetected in PTU treated rats, which was expressed along the plasma membrane 
between principal and basal cells throughout the epididymis in untreated age-matched controls [14]. 
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Also, another recent work suggested that CX43 could be an intermediate target for T3 to inhibit 
neonatal Sertoli cell proliferation [8]. 
Link between cell cycle regulators and connexin 43 
   Gap junctional communication plays a crucial role in cell proliferation. Hexameric 
assembly of connexins is transported to the plasma membrane to create a connexon that can 
associate with connexons on nearby cells to create cell-to-cell channels. Clusters of these channels 
assemble to make gap junctions. Phosphorylation of CX43 is important in regulating assembly and 
function of gap junctions. There are various phosphorylated forms of CX43. The ability of cells to 
process CX43 to the P2 phosphorylated form resulted in functional gap junctions [100]. CX43 is a 
well-known tumor suppressor gene. The expression levels of Cx43 transcript as well as CX43 
protein were profoundly decreased in several human brain tumor cell lines. Transfection of human 
Cx43 into human glioblastoma
 
cell lines profoundly reduced cell proliferation [101].
 
Inhibition of 
gap junctional coupling in astrocytes increased the percentage of astrocytes found in the S, G2 and 
M phases of the cell cycle, with a concomitant decrease in G0 and G1 phases. Also, gap junctional 
uncoupling resulted in increased phosphorylation of retinoblastoma protein, which was observed 
during passage of the cells from a quiescent state to the cell cycle. In addition, the levels of cyclins, 
D1 and D3 were increased, whereas those of CDKIs, p27
Kip1 
and p21
Cip1 
were not significantly 
modified [102]. The mechanism by which CX43 inhibit tumor progression is by suppressing SKP2, 
which in turn results in cell cycle arrest due to high p27
Kip1
 concentrations [103-105]. Moreover, C-
terminal domain of CX43 that did not form gap junctions was sufficient to inhibit expression of 
SKP2, whereas the N-terminal domain that formed the gap junctions did not show such an effect 
[103]. Also, Zhang et al (2003) demonstrated that Cx43 increased p27
Kip1
 expression only in the 
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presence of SKP2 in mouse embryo fibroblasts, indicating that SKP2 plays a critical role in the 
CX43-induced p27
Kip1
 up-regulation [103]. 
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CHAPTER II 
PROLIFERATION OF ADULT SERTOLI CELLS FOLLOWING CONDITIONAL 
KNOCK OUT OF THE GAP JUNCTIONAL PROTEIN CONNEXIN 43 
 
This chapter was published in Biology of Reproduction, and the citation is given below  
Proliferation of adult Sertoli cells following conditional knockout of the Gap junctional protein 
GJA1 (connexin 43) in mice. 
Sridharan S, Simon L, Meling DD, Cyr DG, Gutstein DE, Fishman GI, Guillou F, Cooke PS. 
Biol Reprod. 2007 May;76(5):804-12. 
 
ABSTRACT 
 Connexin 43 (CX43) is the predominant testicular gap junction protein, and CX43 may 
regulate Sertoli cell maturation and spermatogenesis.  I hypothesized that lack of CX43 would 
inhibit Sertoli cell differentiation and extend proliferation.  To test this, a Sertoli cell-specific Cx43 
knockout (SC-Cx43 KO) mouse was generated using Cre-lox technology.  Immunohistochemistry 
indicated that CX43 was not expressed in Sertoli cells of SC-CX43 KO mice, but was normal in 
organs such as heart.  Testicular weight was reduced by 41% and 76% in SC-Cx43 KO mice at 20 
and 60 days, respectively, vs. wild-type (wt) mice.  Seminiferous tubules of SC-Cx43 KO mice 
contained only Sertoli cells and actively proliferating early spermatogonia.  Sertoli cells normally 
cease proliferation at two weeks of age in mice and become terminally differentiated.  However, 
proliferating Sertoli cells were present in SC-Cx43 KO mice, but not wt, at 20 and 60 days of age.  
Thyroid hormone receptor 1 (TR 1) is high in proliferating Sertoli cells, then declines sharply in 
adulthood.  TR 1 mRNA expression was increased in 20-day SC-Cx43 KO vs. wt mice, and 
showed a trend toward an increase in 60-day mice, indicating that loss of CX43 in Sertoli cells 
inhibits their maturation. In conclusion, I generated mice lacking CX43 in Sertoli cells, but not 
other tissues. Data indicate that CX43 in Sertoli cells is essential for spermatogenesis but not 
spermatogonial maintenance/proliferation. SC-Cx43 KO mice showed continued Sertoli cell 
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proliferation and delayed maturation in adulthood, indicating that CX43 plays key roles in Sertoli 
cell development. 
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INTRODUCTION 
  Gap junctions are intercellular channels that connect the cytoplasm of adjoining cells, 
allowing intercellular passage of small (< 1.5 kDa) molecules and regulating essential processes 
during development and differentiation. In seminiferous epithelium, gap junctional coupling 
occurs between Sertoli cells and adjacent Sertoli cells, spermatogonia and spermatocytes [5]. Each 
gap junction channel is comprised of two hemichannels or connexons, and each connexon is 
formed by aggregation of six protein subunits known as connexins (Cxs) [106].   
  Connexin 43 (CX43, also known as GJA1) is the most abundant and ubiquitously 
distributed gap junction protein in testis [2]. Various knockout mouse models have demonstrated 
the importance of CX43 in spermatogenesis. Cx43 knockout (Cx43 KO) mice were not viable 
postnatally due to cardiac malformation and the testes were hypotrophic because of a severe germ 
cell deficiency [9]. When testes from Cx43 KO fetuses were grafted under the renal capsules of 
adult males, the seminiferous epithelium showed a Sertoli cell-only phenotype with only a few 
germ cells, which indicated that CX43 is required for postnatal germ cell expansion [13]. The 
requirement for CX43 is tissue-specific; when Cx43 was replaced with connexin 40 (also known as 
GJA5) using a knock-in model, the cardiac malformation responsible for lethality of the global 
knockout was reversed and the animals were viable. However, seminiferous epithelial 
abnormalities seen in Cx43 KO mice persisted in the connexin 40 knock in [11], illustrating an 
essential and non-redundant role of CX43 in the testis despite the ability of other CXs to 
effectively substitute for CX43 in heart. CX43 may also play a critical role in human 
spermatogenesis, as indicated by the recent report that CX43 was reduced in infertile men with 
secretory azoospermia [6]. 
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  CX43 has also been implicated in regulation of cell growth and differentiation, both in 
normal and tumor cells [107]. For example, forced CX43 expression in lung and liver carcinoma 
cells in vitro [108] decreases their proliferation. This may be partially due to its role in gap 
junctions, but CX43 also plays a role in growth regulation independent of its role in gap junctions. 
This is illustrated by the finding that blockade of gap junction function does not abolish the ability 
of CX43 to regulate cell proliferation, and a mutant form of CX43 that lacks gap junction activity 
is as effective as native CX43 in suppressing cell growth [109]. This role of CX43 may reflect 
effects on the cell cycle machinery. CX43 expression in neoplastic cells in vitro results in 
increased expression of the cyclin-dependent kinase inhibitor p27
Kip1
, (also known as CDKN1B) 
which may mediate growth inhibitory effects of CX43 [108]. Furthermore, in human 
osteosarcoma cells, transfection of CX43 inhibited the ubiquitination and subsequent degradation 
of S-phase kinase-associated protein 2 (Skp2, also known as p45) [104], another cell cycle protein 
that is the major regulator of p27
Kip1
. Thus, CX43 actions on cell proliferation may involve 
actions on cell cycle proteins.  
  We and others have previously shown that thyroid hormone is a major regulator of Sertoli 
cell proliferation and maturation, and that thyroid hormone effects may involve p27
Kip1
 and SKP2 
([30, 110, 111]; Oki et al, unpublished data). Furthermore, CX43 in neonatal rats was localized 
predominantly in the cytoplasm of Sertoli cells, where it is believed to be inactive. However, 
during the pubertal period when Sertoli cells undergo terminal differentiation, CX43 becomes 
localized to the plasma membrane, where it is presumably active. This process was inhibited by 
neonatal hypothyroidism [14], suggesting that CX43 in Sertoli cells could be involved in 
mediating the inhibitory role of thyroid hormone on Sertoli cell proliferation. In addition, a recent 
study using the 42GPA9 Sertoli cell line demonstrated that thyroid hormone increases expression 
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of CX43 and reduces proliferation in this cell line, again suggesting that CX43 regulates Sertoli 
cell proliferation and may mediate thyroid hormone effects on this process [112].   
  Based on emerging literature that CX43 is important in Sertoli cells and that CX43 has 
regulatory effects on proliferation in cell lines, we hypothesized that CX43 could be a major 
regulator of Sertoli cell proliferation. However, the neonatal lethality of the Cx43 KO precludes a 
simple analysis of Sertoli cell number in adults to test this hypothesis. An alternative method for 
addressing this question is to make a conditional knockout lacking CX43 expression only in 
Sertoli cells. Conditional Cx43 KO mice lacking CX43 in the heart have been developed [113-
116]. These mice are produced by mating mice expressing Cre recombinase (Cre-R) under the 
control of a cardiac-specific promoter to mice where the CX43 gene is flanked by loxP sites, or 
“floxed”. A loxP site is a 34 base-pair DNA recognition sequence of the Cre-R enzyme. The Cre-
R enzyme recognizes and cuts out the intervening DNA between 2 loxP sites. The Cre/Lox 
excision activity is highly efficient for producing tissue-specific recombination events in mice.  
  Lecureuil et al [117] have developed mice expressing Cre-R in Sertoli cells under the 
control of the AMH promoter. This mouse, in conjunction with mice containing floxed Cx43 
genes [113-116] was used here to produce a conditional Cx43 KO lacking CX43 only in Sertoli 
cells. Our results show that loss of Sertoli cell CX43 dramatically alters Sertoli cell proliferation 
and maturation, indicating that CX43 is a major regulator of Sertoli cell development. 
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MATERIALS AND METHODS 
Animals and animal care 
 Transgenic mice expressing Cre recombinase under the control of the Amh gene promoter 
were obtained from INRA (National Institute for Agronomic Research), Paris, France [117]. 
Female homozygous Cx43 floxed mice, in which the CX43 coding region is flanked by two loxP 
sites in both Cx43 alleles, were developed as described previously [113-116]. 
 Mice were housed at 25°C with 12L:12D cycles and given water and a standard rodent 
diet ad libitum. All animal experiments were approved by the IACUC of the University of 
Illinois and conducted in accordance with the National Institutes of Health (NIH) Guide for the 
Care and Use of Laboratory Animals. 
Generation of SC-Cx43 KO mice  
 Transgenic Amh-Cre (C57BL/6) male mice expressing Cre recombinase under the control 
of the Amh gene promoter were bred with C57BL/6 female mice containing two floxed copies of 
CX43. Mice heterozygous both for the Amh-Cre and the floxed Cx43 were then mated with 
either mice heterozygous for Amh-Cre and floxed Cx43 obtained from the initial mating or mice 
that had been bred an additional generation to obtain animals that were lacking Amh -Cre and 
homozygous for floxed Cx43 (figure 1). These matings yielded SC-Cx43 KO mice along with 
other genotypes. Based on previous reports that one copy of the Amh-Cre was sufficient to excise 
floxed androgen receptor gene and create a conditional androgen receptor knock out in Sertoli 
cells [40], we anticipated that expression of Amh promoter-driven Cre recombinase would 
efficiently and selectively delete the floxed Cx43 gene in Sertoli cells even when only one copy 
of Amh-Cre was present. 
  
22 
 
Genotyping  
 Animals were genotyped using tail genomic DNA with the DNeasy tissue kit (Qiagen, 
Valencia, CA) according to the manufacturer‟s instructions.  SC-Cx43 KO mice (Amhwt/Cre, 
Cx43
flox/flox 
or Amh
Cre/Cre
, Cx43
flox/flox
) expressed two floxed Cx43 and one or two Cre alleles, 
whereas control animals for Cre (Amh
Cre/Cre
, Cx43
wt/wt 
or Amh
wt/Cre
, Cx43
wt/wt
) expressed one or 
two Cre alleles but not floxed alleles and control animals to evaluate the effects of the floxed 
Cx43 gene alone (Amh
wt/wt
, Cx43
flox/flox 
or Amh
wt/wt
, Cx43
wt/flox
) expressed no Cre but one or two 
floxed alleles. Heterozygous mice (Amh
wt/Cre
,
 
Cx43
wt/flox 
or Amh
Cre/Cre
,
 
Cx43
wt/flox
) expressed both 
Cre and floxed alleles (one or more Cre alleles with one floxed allele) and wt mice (Amh
wt/wt
,
 
Cx43
wt/wt
) expressed neither Amh-Cre nor floxed Cx43 alleles.  
Experimental groups 
 Body and testis weights were measured for all genotypes (figure 1) at 20 and 60 days of 
age. For all other experiments, only 20- and 60-day-old wt and SC-Cx43 KO mice were used. 
Immunohistochemistry (IHC) 
 Testes of 20d mice were fixed by immersion in 10% neutral-buffered formalin (NBF), 
while those from 60d mice were fixed by whole-body vascular perfusion using 10% NBF. Fixed 
testes were embedded in paraffin using standard techniques. Embedded testes were sectioned at 4
 
µm, deparaffinized and rehydrated. To facilitate
 
antigen detection of all proteins except for 
CX43, slides were placed in boiling 10 mM sodium
 
citrate buffer (pH = 6.0) for 10 min and then 
cooled to ambient
 
temperature. Endogenous peroxidase activity was quenched by
 
incubation with 
0.3% H2O2 for 20 min. Binding
 
of primary antibody was localized using the Vectastain ABC Kit 
(Vector Laboratories, Burlingame, CA) for each antibody
 
and DAB Substrate Kit (Vector) 
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according to the manufacturer's instructions. Negative controls were processed without the 
corresponding primary antibody. 
IHC for CX43  
 Heart and testis of adult wt and SC-Cx43 KO mice were immersion-fixed in Bouin‟s fluid 
overnight, dehydrated in 70% ethanol and embedded in paraffin. Tissue sections were 
deparaffinized in HistoClear (Fisher Scientific, Ottawa, ON, Canada) and rehydrated by 
immersion in a series of graded ethanols. IHC was done using the DAKO Catalyzed Signal 
Amplification System (DAKO, Carpenteria, CA) according to the manufacturer‟s instructions. 
Tissue sections were incubated overnight at 4°C with anti-CX43 antisera (2 g/ml; Santa Cruz 
Biotechnology, Santa Cruz, CA).  CX43 expression was detected using an anti-rabbit horseradish 
peroxidase-conjugated secondary antiserum (DAKO), according to the manufacturer‟s 
instructions. Sections were counterstained with methylene blue. Tissue sections incubated with 
normal rabbit serum were used as a negative control. 
IHC for Wilm’s Tumor 1 (WT1) and MKi67  
 To assess Sertoli and germ cell proliferation in wt and SC-CX43 KO mice (n = 4 per 
genotype),
 
serial testes sections were stained for a Sertoli cell marker, WT1, using a rabbit
 
polyclonal IgG to human WT1 (Santa Cruz Biotechnology) and a cell proliferation marker, 
MKI67, using a mouse anti-human monoclonal IgG to human
 
MKI67 (BD Transduction 
Laboratories, Lexington, KY). Following immunostaining, tissues were counterstained
 
with 
Mayer‟s Hematoxylin (Sigma-Aldrich, St. Louis, MO). The percentage of proliferating Sertoli 
cells was determined by MKI67 staining [118] in ~500 Sertoli cells identified
 
by positive WT1 
staining per testis. We used WT1 staining to calculate total Sertoli cell number per testis based 
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on the count of round objects in sections of known thickness, using the morphometric methods 
previously described [119]. 
Isolation of Sertoli cell RNA 
 Sertoli cells were isolated from wt and SC-Cx43 KO mice at 20 and 60 days of age by 
sequential
 
enzymatic digestion with 0.1% collagenase, 0.1% hyaluronidase with trypsin and 
trypsin inhibitor with 0.5% BSA, as previously described [111]. Total RNA was isolated from 
Sertoli cell samples using the Qiagen RNeasy Mini RNA Isolation kit (Qiagen, Valencia, CA) 
according to the manufacturer‟s instructions. RNA samples were quantified with a NanoDrop 
spectrophotometer (NanoDrop, Wilmington, DE).  All RNA samples isolated had an A260/280 
ratio of 1.9-2.2. Random RNA samples were also examined for integrity by 1% agarose gel 
electrophoresis, and stained with 0.5 µg/ml ethidium bromide. RNA samples were stored at -
20ºC after isolation. 
Real-time PCR 
 First strand cDNA was synthesized from total RNA (1 g) using Superscript reverse 
transcriptase and random primers (Invitrogen, Carlsbad, CA). Real-time PCR was performed 
using the ABI Prism 7000 Sequence detection system with validated ABI Taqman gene 
expression assays (Applied Biosystems, Foster City, CA). The expression value of thyroid 
hormone receptor 1 (TR 1, also known as THRA1) mRNA was normalized to the amount of 
an internal control gene (18S ribosomal RNA) to calculate a relative amount of RNA in each 
sample. The expression value of TR 1 gene in the wt sample was arbitrarily defined as 1 unit. 
All assays were carried out in triplicate for the TR 1 mRNA and the normalized expression 
values for all wt samples and SC-Cx43 KO samples averaged. A relative quantitative fold change 
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was determined using the ∆∆Ct method (ABI Chemistry Guide# 4330019). The ABI Taqman 
gene expression assay used for TR 1 transcript was MA00617505-A1. 
Statistical Analysis  
 For body and testis weights, data were analyzed with one-way ANOVA. All other data 
were analyzed using Student‟s t test and presented as mean ± SEM. Differences were considered 
significant at p < 0.05. Statistical analysis was carried out using Graph Pad Prism 4.0 (Graph Pad 
Software, Inc., San Diego, CA).   
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RESULTS 
Effect of loss of CX43 in Sertoli cells on body and testis weights 
 Body weights in wt and SC-Cx43 KO mice were comparable at 20 and 60 days of age 
(figure 2A). Conversely, testis weights (figure 2B) were significantly less at both ages in SC-
Cx43 KO mice (11.4 ± 1.2 and 22.1 ± 2.5 mg, respectively) compared to wt mice (20.3 ± 2.9 and 
91.0 ± 6.7 mg, respectively). Testis weights were reduced 41% (p < 0.05) and 76% (p < 0.00001) 
in SC-Cx43 KO mice at 20 and 60 days of age, respectively, compared to age-matched wt mice. 
Mice heterozygous or homozygous for Amh-Cre and with one or no floxed Cx43 alleles did not 
show any significant changes in body or testes weights compared to wt mice at 20 and 60 days of 
age (data not shown). Similarly, mice heterozygous or homozygous for floxed Cx43, but without 
Amh-Cre, also had body and testes weights that were not significantly different from wt controls 
(data not shown). 
CX43 expression in testis and heart of conditional Cx43 knockouts 
 CX43 was expressed in Sertoli, Leydig, peritubular, myoid and germ cells of wt mice 
(figure 3A). Conversely, CX43 staining was detected in all of these cell types except Sertoli cells 
in SC-Cx43 KO testis (figures 3B, C, D). In addition, CX43 expression was strong and 
comparable in hearts of both wt (figure 3E) and SC-Cx43 KO mice (figure 3F), indicating that 
loss of Sertoli cell CX43 seen in SC-Cx43 KO mice was not accompanied by loss of CX43 in 
other organs. Excision of CX43 was detected by PCR in Sertoli cells from SC-Cx43 KO, but not 
in heart from these animals (data not shown), confirming the IHC results. 
Testicular histology of SC-Cx43 KO 
 Normal spermatogenesis was initiated in wt mice at day 20 (figure 4A), and full 
spermatogenesis was seen at day 60 (figure 4C). Spermatogenesis was absent at 20 and 60 days 
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in SC-Cx43 KO mice (figures 4B, D and E). At both ages, seminiferous tubules had a Sertoli 
cell-only phenotype with a few early stage germ cells. Seminiferous tubules of SC-Cx43 KO 
mice were vacuolated and this was more pronounced at 60d (figures 4D and E). SC-Cx43 KO 
testis contained extensive interstitial cells and this was more prominent at 60d (figures 4D and 
E). However, this may be due to decreased size of seminiferous tubules and testes in SC-Cx43 
KO mice, rather than hyperplastic changes in the interstitium. 
 Sloughing of Sertoli cells from the basement membrane was also observed in SC-Cx43 
KO mice. Sloughed cells formed clusters inside tubule lumens and this was more prominent at 
60d (figure 4E). 
 MKI67 staining indicated that some germ cells were proliferating at 20 and 60 days of 
age in SC-Cx43 KO mice (not shown). Thus, lack of Sertoli cell CX43 does not preclude 
proliferation of remaining germ cells. 
Loss of CX43 in Sertoli cells extends their proliferation  
 We observed a lack of Sertoli cell proliferation in wt testes at 20 and 60 days of age in 
the present study (figures 5A and B), consistent with previous reports that Sertoli cells normally 
cease proliferation by approximately two weeks of age in mice [120]. In contrast, in SC-Cx43 
KO mice, Sertoli cells were still proliferating at 20 and even 60 days of age (figures 5C and D). 
Sertoli cell proliferation, as determined by labeling index (n = 4 per genotype), was 2.2% ± 0.3% 
(p < 0.00001) and 1.3% ± 0.1% (p < 0.000001) in 20- and 60-day-old SC-Cx43 KO mice, 
whereas in wt mice Sertoli cell proliferation was 0.02 ± 0.02% at 20 days of age, and absent at 
60 days (figures 6A).  
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Effect of loss of Sertoli cell CX43 on adult Sertoli cell number 
 Sertoli cell number was increased in SC-Cx43 KO mice compared to wt mice at 20 and 
60 days of age (figure 6B). There was no significant difference in Sertoli cell number between 
20d and 60d wt mice, consistent with earlier findings that Sertoli cell mitogenesis ceases before 
weaning [120]. Sertoli cell numbers in 20d (6.66 ± 0.98 x 10
6
, p < 0.05) and 60d (6.06 ± 0.99 x 
10
6
, p < 0.05) SC-Cx43 KO mice were significantly increased compared to wt mice (3.85 ± 0.14 
x 10
6
 and 3.50 ± 0.37 x 10
6
, respectively). Sertoli cell number was increased by 73% in both 20 
and 60d SC-Cx43 KO mice, despite a 41% and 76% reduction in testis weight, respectively, 
compared to wt mice.   
Effect of loss of Sertoli cell-CX43 on TRα1 expression 
 TR 1 expression in Sertoli cells is indicative of maturational state, with high neonatal 
expression followed by steady decreases to minimal levels in adults [45, 63, 121]. There was a 
significant 166% increase (p < 0.05) in TR 1 mRNA expression in SC-Cx43 KO mice compared 
to wt mice at 20d (figure 6C). At 60d, TR 1 mRNA expression in SC-Cx43 KO mice was 
increased 44% and showed a trend toward an increase compared to age-matched wt mice, but 
this did not reach significance (p = 0.16).   
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DISCUSSION 
 CX43 is the predominant gap junctional protein in the testis of both the rat [2, 12] and 
human [6, 15], and appears to have critical effects on spermatogenesis [9, 13]. Work in other cell 
types suggests that CX43 may also regulate cell proliferation [107, 108] and thus could have 
effects on Sertoli cell mitogenesis and the establishment of the ultimate Sertoli cell number. 
However, this question was problematic to address due to neonatal lethality of the global 
knockout [122]. In this study, a Sertoli cell-specific Cx43 knockout model was used to determine 
the role of CX43 in Sertoli cell development.  
 The lack of CX43 expression in Sertoli cells of the SC-Cx43 KO mice in this study 
indicate that the Cre/lox methodology utilized has resulted in a conditional knockout of Sertoli 
cell Cx43 expression. The lack of Sertoli cell CX43 contrasts with the continued robust 
expression in other testicular cell types such as peritubular, myoid, Leydig and germ cells. 
Similarly, heart normally expresses CX43, and mice with a global knockout of Cx43 die from 
heart abnormalities [122]. Our results show that heart, which is dependent on CX43 for normal 
development, expresses CX43 normally and is functional in the SC-Cx43 KO mice. These results 
further indicate that generation of mice lacking CX43 only in Sertoli cells was successful. At the 
same time CX43 expression is maintained in other cell types in this animal model. 
 Body weights of SC-Cx43 KO mice were comparable to wt mice. This contrasted with 
the sharp decreases in testis weight seen at 20 and especially 60 days of age. The lack of Sertoli 
cell CX43 resulted in the absence of spermatogenesis and concomitant decreases in overall testis 
weight compared to the wt control, where spermatogenesis was normal. The lack of effect on 
body weight is consistent with immunohistochemical results that indicate a loss of CX43 
exclusively in Sertoli cells of the testis.  
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 Mice in which Amh-Cre and/or floxed Cx43 is present, but animals that do not have the 
combination of two floxed alleles and Amh-Cre necessary to produce a deletion of CX43, 
function as critical controls to ensure that observed effects on various testicular parameters are 
indeed due to specific deletion of Sertoli cell CX43, rather than potential non-specific deleterious 
effects caused by independent effects of either floxing the Cx43 gene or the expression of Amh-
Cre. The lack of any statistically significant changes in either body or testicular weights in mice 
expressing Amh-Cre and/or floxed Cx43 but not having the genotype that results in a conditional 
knockout indicates that neither the floxed Cx43 or Amh-Cre alone had significant deleterious 
effects on either of these parameters.  
 In mice, Sertoli cells are proliferating actively at birth and then show declining rates of 
proliferation during the neonatal period up to approximately two weeks of age. Sertoli cell 
mitogenesis then ceases and the cells undergo terminal differentiation [29], which involves the 
expression of a variety of factors implicated in supporting spermatogenesis and the development 
of the actin cytoskeleton [123]. In addition, morphological changes such as the formation of the 
Sertoli cell barrier are accompanied by adluminal secretion of Sertoli cell fluid, which leads to 
canalization of the seminiferous cord. Once Sertoli cells are terminally differentiated, they 
remain non-mitogenic under normal conditions in mice. The mechanisms involved in Sertoli cell 
proliferation and differentiation, as well as the transition between these two states, are not fully 
understood. 
 Our present results indicate that the lack of CX43 expression in Sertoli cells allows them 
to remain proliferative well into adulthood. The oldest age examined in our present study was 
day 60, but it is likely that Sertoli cells in SC-Cx43 KO mice continue proliferating throughout 
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life. The continued Sertoli cell proliferation in SC-Cx43 KO mice suggests that maturation of 
these cells must be inhibited, as full maturational changes in Sertoli cells cannot occur until 
proliferation has ceased. TR 1 mRNA expression is a sensitive indicator of maturational state in 
Sertoli cells, being high during the neonatal proliferative period and declining to minimal levels 
as the Sertoli cell mature and become post-mitotic. The increased TR 1 mRNA expression in 
Sertoli cells of SC-Cx43 KO compared to wt mice strongly supports the idea that Sertoli cell 
differentiation is inhibited by lack of CX43 and these results are consistent with the observed 
continued proliferation of these cells. Thus, absence of CX43 blocks the maturational sequence 
that Sertoli cells normally undergo during neonatal life that culminates in them eventually 
becoming post-mitotic and showing morphological and functional differentiation.    
 CX43 expression in Sertoli cells first occurs at puberty and serves as a pubertal 
differentiation marker in species such as pig, guinea pig and man [124]. In the rat, CX43 was 
initially localized to both the plasma membrane and cytoplasm of Sertoli cells during postnatal 
development. By day 30, CX43 expression was entirely along the basement membrane [2, 12]. In 
contrast, hypothyroidism resulted in impairment of this normal maturational sequence and 
continued localization of CX43 in the cytoplasm at day 30, where it is presumed to be non-
functional. Hypothyroidism is associated with an increased period of neonatal proliferation [125] 
and an ultimate large increase in adult Sertoli cell numbers [119]. The present results showing a 
critical regulatory role for CX43 in Sertoli cell proliferation, in concert with previous data 
showing that thyroid hormone effects developmental expression of CX43 [112, 126] as well as 
Sertoli cell proliferation in vivo [125] and in vitro [38], indicates that thyroid hormone effects on 
CX43 may be critical to understanding how thyroid hormones induce maturational changes that 
normally render Sertoli cells post-mitotic during juvenile development in rodents in vivo. This 
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conclusion is strongly supported by recent in vitro data using a Sertoli cell line, in which thyroid 
hormone increased CX43 and inhibited proliferation of these cells [112]. 
 The continued Sertoli cell proliferation in SC-Cx43 KO mice would be expected to lead 
to increased adult Sertoli cell populations in these mice, and indeed such increases in Sertoli cell 
populations were observed. However, increases in Sertoli cell populations in SC-Cx43 KO mice 
are modest based on the continued robust proliferation of Sertoli cells in SC-Cx43 KO mice into 
adulthood. This apparent discrepancy is explained by our observations that SC-Cx43 KO mice 
have aggregates of cells in the lumen of the seminiferous tubules. Immunostaining identified 
these as Sertoli cells, and these cells appear to have been sloughed from the seminiferous 
epithelium. The continued proliferation of Sertoli cells in SC-Cx43 KO mice into adulthood may 
lead to an excessive build-up of Sertoli cells along the basement membrane of the tubule, and 
this may result in sloughing and loss of some Sertoli cells as their proliferation continues.    
 In SC-Cx43 KO mice, the seminiferous tubules had Sertoli cells and a few early stage 
spermatogonia; some of those spermatogonia were actively proliferating. Our results with the 
conditional Cx43 KO confirm the earlier study of Roscoe et al [13], who also observed 
proliferation of early stage germ cells when they grafted Cx43 KO testes under the renal capsules 
of adult male mice for up to 3 weeks. The lack of continued development of germ cells past an 
early stage likely results from the immaturity of the Sertoli cells lacking CX43 as well as the lack 
of gap junctional communication with the Sertoli cells. However, our results and the previous 
work of Roscoe et al [13] indicate that even in the absence of CX43, Sertoli cells can support 
development of fetal germ cells (primordial germ cells and gonocytes) and the differentiation of 
spermatogonia from these cells, although the Sertoli cells are not capable of supporting more 
advanced stages of spermatogenesis.  
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 FSH is the major mitogen for Sertoli cells, but Sertoli cell proliferation decreases and 
then stops neonatally despite continued presence of FSH [33] and increasing expression of FSH 
receptor [127]. Thyroid hormones stimulate maturational events that result in the cessation of 
Sertoli cell proliferation and the concomitant stimulation of functions characteristic of the mature 
Sertoli cell, as described above. These thyroid hormone effects on Sertoli cell proliferation may 
involve effects on cell cycle proteins such as p27
Kip1
, p21
Cip1
 (also known as CDKN1A) and 
SKP2 [30, 110, 111, 128]. In addition, elegant work by Chaudhary et al [58] had demonstrated 
that overexpression of the inhibitor of differentiation (ID) proteins in post-mitotic terminally 
differentiated Sertoli cells caused them to reenter the cell cycle and proliferate indefinitely. The 
potential interrelationships between CX43, cell cycle proteins such as p27
Kip1
, p21
Cip1
 and Skp2, 
and the ID proteins in the events that normally accompany the transition of a Sertoli cell from a 
proliferative to a mature, post-mitotic state during development still remain to be established, but 
work in this area should yield additional insights into the complex and important process of 
Sertoli cell differentiation.  
 In conclusion, generation of a Sertoli cell-specific Cx43 knockout was successful and 
shown that CX43 in Sertoli cells is essential for spermatogenesis but not for maintenance and 
proliferation of spermatogonia. Critically, SC-Cx43 KO mice showed continued Sertoli cell 
proliferation long after Sertoli cell proliferation had ceased in wt mice, but had inhibited Sertoli 
cell differentiation. Results suggest that CX43 plays a key inhibitory role in controlling Sertoli 
cell proliferation and is essential for normal maturation of Sertoli cells in mice.  
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FIGURES 
 
 
 
Figure 1. Generation of SC-Cx43 KO mice.  Transgenic Amh-Cre (C57BL/6) male mice expressing Cre recombinase under the 
control of the Amh gene promoter were bred with C57BL/6 female mice containing two floxed copies of Cx43.  Mice heterozygous 
both for Amh-Cre and floxed Cx43 were then mated with either mice heterozygous for Amh-Cre and floxed Cx43 obtained from the 
first mating or mice that had been bred an additional generation to obtain animals that were homozygous for floxed Cx43 to yield SC-
Cx43 KO, Cre and flox controls, heterozygous and wild-type mice. 
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Figure 2. Body and testis weights of wt and SC-Cx43 KO mice.  A) Body weights of wt and 
SC-Cx43 KO mice were comparable at 20d and 60d.  B) Testis weights were significantly 
reduced in 20d and 60d SC-Cx43 KO mice compared to wt controls.  All data are expressed as 
mean ± SEM (n = 5 per genotype). Values that do not share a common superscript are 
significantly different from the similarly aged control.   
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Figure 3. Immunolocalization of CX43 in testis and heart of adult wt and SC-Cx43 KO 
mice. 
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Figure 3 (cont.). Immunolocalization of CX43 in testis and heart of adult wt and SC-Cx43 
KO mice.  A) CX43 (black arrows) in wt mice was localized to Sertoli cells at the basal region 
of the seminiferous tubule (ST).  CX43 was also localized more apically in the Sertoli cells 
(white arrows) and appeared localized between spermatids.  Immunoreactivity was also observed 
between Leydig cells (not shown).  B) In SC-Cx43 KO mice, CX43 immunostaining was absent 
between adjacent Sertoli cells.  However, apical CX43 immunoreactivity between developing 
germ cells (white arrows) was present, as was immunoreactivity between Leydig cells (L).  Most 
tubules contained vacuoles (V) that appeared to be surrounded by a plasma membrane.  C) In 
some tubules immunoreactivity was noted in the nuclei of germ cells (narrow arrow).  The 
number of immunopositive nuclei varied between tubules but appeared to be consistent and was 
not observed in wt mice. Immunoreactivity between Leydig cells (open arrow) is also present. D) 
Cx43 was also observed in myoid cells (black arrows).  Heart was used as a positive control (E-
F).  E) In wt mice, Cx43 was observed between cardiac myocytes (black arrows).  In SC-Cx43 
KO mice, Cx43 was present and also appeared to be localized to cardiac myocytes.  Intensity of 
Cx43 immunoreaction in the heart sections of SC-Cx43 KO mice was comparable with wt mice.  
Magnification = 240X for figures 3A, B, C and D and 400X for figures 3E and F. 
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Figure 4. Testicular histology of 20d and 60d wt and 20d and 60d SC-Cx43 KO mice. 
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Figure 4 (cont.). Testicular histology of 20d (A) and 60d wt (C) and 20d (B) and 60d (D, E) 
SC-Cx43 KO mice. Spermatogenesis was absent in SC-Cx43 KO mice at both ages (B, D and 
E).  The SC-Cx43 KO testis had a Sertoli cell-only phenotype with a few germ cells in the 
seminiferous tubules at both 20d (B) and 60d (D and E).  Vacuoles (V) were present in tubules of 
SC-Cx43 KO mice (black arrows) at both 20 and 60d.  In SC-Cx43 KO testis there was a relative 
increase in interstitial cells (IS) due to reduced overall testicular size (D and E).  In addition, the 
presence of clusters of sloughed Sertoli cells (arrows) inside the lumen was pronounced in 60d 
SC-Cx43 KO testis (E).  Magnification = 100X for Figs. 5A, B, C and D and 200X for Figure 
5E. 
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Figure 5. Immunohistochemistry of serial testicular sections for WT1 and MKI67. 
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Figure 5 (cont.). Immunohistochemistry of serial testicular sections for WT1 (A and C) and 
MKI67 (B and D).  Cells stained for WT1 are Sertoli cells and those immunopositive for 
MKI67 are proliferating cells.  A) In 60d wt testis, cells immunopositive for WT1 (black arrows) 
are Sertoli cells and all germ cells (white arrows) were immunonegative for WT1.  B) In the 
adjacent section stained for MKI67, cells immunopositive for WT1 (figure 5A) were 
immunonegative for MKI67 (black arrows), while some of the germ cells (white arrows) were 
immunopositive for MKI67.  C) In 60d SC-Cx43 KO testis, cells immunopositive for WT1 are 
Sertoli cells. Sloughed cells (black arrow) forming clusters in the lumen stained for WT1, 
indicating that they were Sertoli cells. D) In the corresponding serial section stained for MKI67, 
some cells immunopositive for WT1 (figure 5C) were immunopositive for MKI67, indicating 
that in SC-Cx43 KO mice Sertoli cells were proliferating even at 60 days of age. Magnification = 
400X.  
  
43 
Figure 6. Effects of loss of Sertoli cell Cx43 on proliferation of Sertoli cells, Sertoli cell 
number and TR 1 mRNA expression in testes of 20d and 60d wt and SC-Cx43 KO mice. 
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Figure 6 (cont.). Effects of loss of Sertoli cell Cx43 on proliferation of Sertoli cells (A), 
Sertoli cell number (B) and TR 1 mRNA expression (C) in testes of 20d and 60d wt and 
SC-Cx43 KO mice. A) Significant Sertoli cell proliferation seen in SC-Cx43 KO mice, 
compared to wt mice at both 20d and 60d where Sertoli cell proliferation was essentially absent. 
B) Sertoli cell number was increased in SC-Cx43 KO compared to wt mice at both 20 and 60d. 
C) Relative TR 1 mRNA expression for SC-Cx43 KO mice at 20d was significantly higher (p < 
0.05) than age-matched wt mice. At 60d mRNA expression was 40% more than that of age-
matched wt mice, although this did not reach statistical significance. Data are expressed as mean 
± SEM (n = 4 per genotype except C, where n = 3 per genotype). Values that do not share a 
common superscript are significantly different. 
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CHAPTER III 
THE RESPONSE OF PROLIFERATING SERTOLI CELLS IN THE SERTOLI CELL-
SPECIFIC CONNEXIN 43 KNOCKOUT TO MITOGENIC AND/OR MATURATION 
INDUCTION STIMULI 
 
ABSTRACT 
 Follicle stimulating hormone (FSH) and thyroid hormone (T3) are the major endocrine 
regulators of Sertoli cell proliferation. Previous studies had shown that neonatal Sertoli cell 
cultures proliferated in response to FSH, whereas adult or juvenile Sertoli cells did not. Also, 
some studies had shown that CX43 was one of the targets of thyroid hormone in Sertoli cell 
development. Results from the previous chapter showed that Sertoli cell maturation was 
impaired in SC-Cx43 KO mice and a significant population of adult Sertoli cells in these KO 
mice proliferated in vivo as well as in vitro in contrast to the age-matched wt Sertoli cells, which 
were terminally differentiated. However, the pattern of Sertoli cell proliferation in this animal 
model was unknown. We hypothesized that the proliferative fraction of Sertoli cells were 
shuttling between resting and active phases of the cell cycle in the SC-Cx43 KO mice. Results 
showed that a significant population of Sertoli cells in the non-proliferative fraction of SC-Cx43 
KO Sertoli cells resumed mitosis in vitro, which indicated that the non-proliferative Sertoli cells 
retained the capacity to proliferate. It was unknown whether the indefinite proliferative phase in 
a significant population of SC-Cx43 KO Sertoli cells would keep them in their neonatal state. It 
was also not known whether these Sertoli cells would respond mitogenically to FSH due to their 
indefinite proliferative phase. Cx43, being a target for the T3 effects on Sertoli cell development, 
it was unknown whether the indefinite in vitro proliferation of SC-Cx43 KO Sertoli cells would 
be stopped by T3 treatment. We hypothesized that juvenile and adult SC-Cx43 KO Sertoli cells 
would respond mitogenically to FSH but not to T3 treatment in terms of Sertoli cell proliferation. 
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However, results showed that SC-Cx43 KO Sertoli cells were unresponsive to both FSH and T3 
at 20 and 60d in contrast to the proposed hypothesis. Strikingly, even neonatal SC-Cx43 KO 
Sertoli cells did not respond to any of these hormones. These results suggested that the indefinite 
proliferation of SC-Cx43 KO Sertoli cells even into adulthood might not be due to the 
maintenance of neonatal state. Also, the Sertoli cell proliferation in SC-Cx43 KO mice might be 
intrinsic and unaltered by any hormonal signals.  
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INTRODUCTION  
 In mice, Sertoli cells actively proliferate at birth and then show declining rates of 
proliferation during the neonatal period up to approximately 2 weeks of age and then undergo 
terminal differentiation. Once Sertoli cells are terminally differentiated, they remain non-
mitogenic under normal circumstances. The mechanism involved in the transition of Sertoli cell 
proliferation to differentiation is unclear.  
 In SC-Cx43 KO mice, Sertoli cell proliferation was extended into the adulthood. Thus, 
the transition from proliferation to differentiation was affected in this animal model. A 
significant population of adult Sertoli cells remained proliferative in vivo as well as in vitro, 
which was not observed in wt mice of the same age. The pattern of proliferation of SC-Cx43 KO 
Sertoli cells was unknown. There are two major possibilities. First, the proliferative fraction of 
Sertoli cells might become non-proliferative and at the same time a new fraction of resting cells 
might become proliferative. Second, there might be a constant subset of indefinitely proliferating 
Sertoli cells in the total Sertoli cell population. It is essential to understand the cell cycle of 
Sertoli cells in this animal model. One of the aims of this chapter was to investigate the pattern 
of SC-Cx43 KO Sertoli cells in vitro. Terminal differentiation of these Sertoli cells may not be 
possible due to the ability of these cells to enter the cell cycle from the resting phase 
intermittently.  
 Endocrine regulators primarily regulate Sertoli cell development. FSH and T3 are the 
major hormones that increase proliferation and stimulate maturational events, respectively, in 
neonatal Sertoli cell cultures, whereas juvenile or adult Sertoli cells do not. However, in SC-
Cx43 KO mice, we observed proliferation of adult Sertoli cells in vivo as well as in vitro, which 
leads to a key question whether this indefinitely extended proliferation would allow the adult 
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Sertoli cells of SC-Cx43 KO mice to proliferate more in response to FSH and cease proliferation 
in response to T3 treatments in vitro. Moreover, some studies suggested a mediatory role of 
CX43 in the T3 effect on Sertoli cell proliferation. Another aim of this chapter was to identify 
whether the juvenile and adult Sertoli cells of SC-Cx43 KO mice would respond to the key 
endocrine regulators of neonatal Sertoli cells in wt mice.  
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MATERIALS AND METHODS 
Experimental animal groups 
 In this chapter, wt (3d-5d and 20d) and SC-Cx43 KO mice at various ages (from 5d to 
60d) were used. Mice were housed at 25°C with 12L:12D cycles and given water and a standard 
rodent diet ad libitum. All animal experiments were approved by the IACUC of the University of 
Illinois and conducted in accordance with the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals. 
Sertoli cell isolation 
 Sertoli cells from wt and SC-Cx43 KO mice were isolated using a sequential enzymatic 
digestion procedure as previously described [129, 130]. Briefly, testes were decapsulated in 
Dulbecco's Minimum Essential Medium/Ham's F-12 (1:1) (DMEM/F-12) (Invitrogen, Carlsbad, 
CA) and washed thrice in DMEM/F-12 medium before subjected to enzymatic digestion. Tissues 
were then resuspended in medium containing 1mg/ml collagenase (Collagenase Type 1A; Sigma, 
St. Louis, MA), 10ug/ml deoxyribonuclease I (DNase; Sigma) and 1mg/ml hyaluronidase 
(Hyaluronidase Type II; Sigma) and aspirated through a sterile pipette to mix gently and then 
incubated at 32 C in a shaking water bath for 10-20 minutes. Resulting tissue fragments were 
separated by gravity sedimentation. The supernatant was discarded and the fragments were 
washed twice with DMEM/F-12. Tissue fragments were digested with DMEM/F-12 containing 
1mg/ml collagenase and 10ug/ml DNase similar as that of the first step digestion with 
collagenase and hyaluronidase. Resulting cell aggregates were harvested by gravity 
sedimentation and then dispersed into a single cell suspension by a 2 minute exposure to 0.05% 
Trypsin with ethylenediaminetetraacetic acid (GIBCO, Grand Island, NY). The cells were 
washed twice and then resuspended in DMEM/F-12 nutritive medium.  
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Preparation and fixation of cell smears  
 A drop of cell suspension was placed on a plus charge slide (Fischer Plus).  This slide 
was then placed in a humidified chamber for 15 minutes at room temperature. Thus, the cells 
were allowed to adhere to the slide without air-drying. Cell smears were fixed with ice cold NBF 
in the humidified chamber for 15-20 minutes. Fixed cell smears were washed with PBS and then 
immersed in 70% ethanol.  
Assessment of purity of isolated Sertoli cells 
 To assess the purity of isolated Sertoli cells, the fixed cell smears were stained for 
Wilm‟s tumor 1 (WT1) antigen, which is a stable Sertoli cell marker, using a rabbit polyclonal 
IgG to human WT1 (1:200; Santa Cruz Biotechnology). Following immunostaining, cells were 
counterstained with Mayer‟s hematoxylin (Sigma-Aldrich, St. Louis, MO). Some of the fixed 
cell smears that were incubated with normal serum without WT1 antibody served as negative 
controls. 
Cell cycle analysis of isolated adult SC-Cx43 KO Sertoli cells using flow cytometry  
 Sertoli cells were isolated from 25d-40d SC-Cx43 KO mice from 5 to 6 litters of atleast  
one KO mouse from each litter. The isolated cells were suspended in DMEM/F-12 medium (0.5-
1 million cells/ml) and incubated in the presence of Hoechst 334342 (Sigma; 2.5-5ug/ml) at 
37 C for 15 minutes. Stained cells were then washed with DMEM/F-12 medium. A fraction of 
isolated Sertoli cells was unstained and served as a negative control. Supravital staining of DNA 
with Hoechst 33342 dye allowed to sort the cells, which were at different phases of the cell cycle 
based on differences in their DNA content using flow cytometry.  
 
Stained cells suspended in the medium were analyzed using a BD Bioscences FACSAria II flow 
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cytometer. The cells were excited with the 355 nm and 488 nm lasers. The emission between 425 
and 475 nm was collected for Hoechst and forward and side scatter light were observed for 
scatter properties of the cells from 488 nm laser.  To avoid doublets from analysis the cells were 
gated for singlets only using dual parameters histogram (Hoechst-area vs. Hoechst-W signals). 
Percentage of cells existing in various phases of the cell cycle was analyzed using FCS Express 
Online software program.  Thus, proliferative fractions of Sertoli cells (S and G2 phases) were 
separated from non-proliferative fractions (G0 phase) by flow cytometry.   
Culture of sorted cell fractions 
 Sertoli cells in G0, S and G2 phases were grown separately in 4-chamber-slides (Nalge 
Nunc International, Rochester, NY) coated with 1:5 diluted matrigel (BD Biosciences, Bedford, 
MA) in DMEM/F-12. Cells were grown for 4 days and fed with fresh medium for every 24 h.  
Cultured cells were then fixed with cold NBF fixative and subjected to immunocytochemistry 
(ICC), which will be explained later in this section.  
Sertoli cell culture and treatment  
 For each culture, Sertoli cells from mice of the same age from 2 or more litters were 
pooled. Sertoli cells were grown in 4-chamber-slides coated with diluted matrigel. Before 
plating, cell number and viability were determined by 0.4% trypan blue exclusion using a 
hemocytometer. Cells were then plated at a density of 2 × 10
5
 cells/chamber. Cells were 
normally grown for 4 days in a humidified atmosphere of 95% air/5% CO2 at 34°C. Medium was 
changed every 24 h and some of the cultures were treated with 100 ng/ml FSH and/or 1 nM T3 
for 48 or 72h. Treatment groups and their corresponding untreated controls are listed in Table 1. 
Untreated control cultures were grown without hormonal supplementation. In a single 
experiment, each chamber represented one replicate. Three independent experiments were 
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performed for each treatment using a separate pool of mice each time. Treatments were 
terminated by removing the medium, then washed in ice-cold PBS for 3 times, and fixed in 4% 
paraformaldehyde for 30 minutes at 4°C. Fixed cells were subjected to ICC 
Immunocytochemistry  
 Fixed cells were permeabilized with 0.5% Triton-X-100 in PBS for 10 minutes. 
Permeabilized cells were incubated with 3% bovine serum albumin (Sigma) in PBS for 30 
minutes at room temperature. The cells were then incubated with anti-MKI67 (cell proliferation 
marker), using a mouse anti-human monoclonal IgG to human MKI67 (1:100; BD Transduction 
Laboratories, Lexington, KY) and anti-GATA4 (Sertoli cell marker), using a goat polyclonal IgG 
(1:100; SantaCruz Biotechnology) for overnight at 4°C. After washing with 0.1% Tween-20 in 
PBS (0.1% PBST), the cells were incubated with fluorescent tagged secondary antibodies 
namely, Alexa Fluor-488 conjugated donkey anti-mouse IgG (Invitrogen, 1:200) and Alexa 
Fluor-594 conjugated donkey anti- goat IgG (Invitrogen, 1:500) for 2 hours at room temperature. 
Cells were washed again in 0.1% PBST and then mounted using Vectashield mounting medium 
with DAPI (Vector). The percentage of proliferating Sertoli cells were determined by MKI67 
staining in approximately 500 or more Sertoli cells. To assess the purity of Sertoli cell culture, 
ICC for WT1 was done in some of the culture samples as described above for cell smears. 
Statistical analysis 
 Statistical analysis was performed using Prism software (GraphPad Software, Inc., San  
Diego, CA).  Differences between treatments were determined using the Student's t-test and were 
considered significant when p < 0.05. 
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RESULTS 
Assessment of the adult Sertoli cell proliferation pattern of SC-Cx43 KO mice in vitro using 
flow cytometry  
 Supravital DNA staining using Hoechst 33342 dye was used to sort the cells in different 
phases of the cell cycle using flow cytometry (figure 7). Flow cytometry sorting of adult SC-
Cx43 KO Sertoli cells in different phases of the cell cycle resulted in 77% 19% and 4% of cells 
in G0, S and G2-M phases, respectively. Thus, non-proliferative and proliferative fractions of 
Sertoli cells from SC-Cx43 KO mice were separated. Immediately after sorting, around 2% of 
cells in the G0 fraction were proliferating, which was identified by cell smear ICC and the 
proliferating cells were significantly lower in G0 fraction than that of the other two fractions 
(figure 8). This indicated that the cell sorting was efficient. After 3 to 4 days culture, when the 
proliferation of Sertoli cell culture were assessed, 5%, 9%, and 4% of Sertoli cells were 
proliferating, in G0, S, and G2 fractions, respectively (figure 9).  
Labeling index of wt and SC-Cx43 KO Sertoli cells in vitro 
 Labeling index (LI) of 5d wt (5.04% ± 0.49%) and SC-Cx43 KO (6.3% ± 0.87%)  
 Sertoli cells cultured for 4 days did not differ significantly (figure 10). However, LI of 20d wt 
(0.28% ± 0.24%) Sertoli cell cultures differ significantly from that of 20d (4.2% ± 0.6%; p < 
0.003) and 60d SC-Cx43 KO (3.1% ± 0.58%; p < 0.01) mice (figure 10). Also, 5d wt Sertoli cells 
showed a marked increase in proliferative fraction of Sertoli cells compared to that of 20d wt 
mice (p < 0.001). Contrary to the wt Sertoli cells, LI of SC-Cx43 KO Sertoli cells at 5d and 20d 
did not differ significantly. At 20d, SC-Cx43 KO Sertoli cells showed a significant increase in 
the proliferative fraction of Sertoli cells compared to their age-matched wt, in which proliferation 
was absent.  Additionally, LI of 20d SC-Cx43 KO was comparable to that of 60d SC-Cx43 KO 
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Sertoli cell cultures. However, 5d SC-Cx43 KO showed more proliferating Sertoli cells than that 
of the 60d SC-Cx43 KO culture (p < 0.05).  
Effect of FSH, T3 and FSH+T3 treatments on Sertoli cell proliferation of 5d wt mice in vitro 
(group A in table 1) 
 LI of FSH-treated Sertoli cells was increased by 81%, compared to the untreated controls 
(p < 0.001).  This was consistent with previous reports, which tested the response of neonatal rat 
Sertoli cells in vitro to FSH [131]. LI of T3 (4.93% ± 0.76%) and FSH + T3 (4.83% ± 0.44%) 
treated Sertoli cells were significantly lower (p < 0.05) than those of FSH (9.13% ± 1.1%) 
treated Sertoli cells (figures 11A, 12A-12D).  This result corroborated with previous reports that 
studied the response of neonatal rat Sertoli cell cultures to FSH and/or T3 [38]. 
Effect of FSH, T3 and FSH+T3 treatments on Sertoli cell proliferation of 20d wt mice in vitro 
(group B in table 1) 
 Proliferation was almost absent in 20d wt Sertoli cell cultures (group B in table 1) and 
these cells did not respond mitogenically to any of the hormone treatments (figures 13A, 14A-
14D).  
Effect of FSH, T3 and FSH+T3 treatments on Sertoli cell proliferation of SC-Cx43 KO mice 
in vitro (groups C, D and E in table 1) 
 Neonatal (5d – figures 11B, 12E-12H), pubertal (20d – figures 13B, 14E-14H) and adult 
(60d – figures 13C, 14I-14L) SC-Cx43 KO Sertoli cell cultures (groups C, D and E, respectively, 
in table 1) did not respond to any hormone treatments.  
 
 
 
55 
 
DISCUSSION 
 Sertoli cell development comprised of two phases in mice: proliferation and 
differentiation. Maximum rate of proliferation occurs during late embryonic and early postnatal 
periods. Proliferation of these cells is essential because each Sertoli cell can support only a fixed 
number of germ cells and thus increased Sertoli cell numbers correlate with increased 
spermatogenic capacity. In rodents, Sertoli cells exit the cell cycle around 15d-21d in rodents. 
They are then no longer mitotic and the final population of adult Sertoli cells is established. 
These cells undergo a differentiation process while mitogenesis is declining.  
 Sertoli cell differentiation includes morphological changes, production of secreted 
proteins that are required for spermatogenesis and formation of specialized junctions between 
those cells that establish the blood-testis barrier [132]. The molecular mechanisms that control 
proliferation and differentiation in Sertoli cells are not fully known. Also, factors that govern the 
transition from proliferation to differentiation phase are unclear. To better understand the Sertoli 
cell development, the ultimate signal that triggers the Sertoli cells to exit the cell cycle needs to 
be determined.  
 CX43 is the predominant gap junction protein in the testis. The specific role of CX43 in 
Sertoli cells was studied using SC-Cx43 KO animal model. Results indicated that CX43 is 
essential for cessation of proliferation and normal maturation in Sertoli cells. A significant 
population of Sertoli cells in SC-Cx43 KO mice proliferated indefinitely in vivo as well as in 
vitro. Reasons for the failure of a significant population of the Sertoli cells to exit the cell cycle 
in this animal model are unknown.  
 The pattern of proliferation of SC-Cx43 KO Sertoli cells in vitro was investigated using 
the Sertoli cell culture system. The first question to be answered was whether the non-
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proliferative SC-Cx43 KO Sertoli cells were either terminally differentiated or quiescent. If they 
were terminally differentiated, thus lacking the potential to divide, then there would be only a 
constant subpopulation of Sertoli cells that was proliferating in the absence of CX43 in Sertoli 
cells. On the other hand, if the SC-Cx43 KO Sertoli cells were quiescent and retain the capability 
to divide, then these cells would reenter the cell cycle at any point of time to maintain a constant 
rate of proliferation in these Sertoli cells.  
 First, the proliferative and non-proliferative fractions were separated using flow 
cytometry. Cells in G0 phase were non proliferative, whereas cells in S and G2 phases were 
proliferative. Cells in G0, S and G2 fractions were cultured separately for 3 to 4 days under 
serum free conditions. LI was increased by 80% in cultured G0 Sertoli cells. Also, LI was 
reduced in S and G2 fractions after 3-4 days of culture. In the absence of Cx43, Sertoli cells may 
shuttle between active and resting phases of the cell cycle and may remain quiescent, which is 
one of the essential characteristics of a stem cell. The presence of Sertoli stem cells has yet to be 
proven. Some previous studies demonstrated that CX43 is a negative marker of stem cells and 
also the gap junctional communication between stem cells in many cell systems is restricted 
[133]. Lack of communication between Sertoli cells in SC-Cx43 KO mice might keep these 
Sertoli cells in a quiescent state.  
 The regulatory role of CX43 in Sertoli cell proliferation is not well understood. Results 
from this study indicated that CX43 expression in Sertoli cells might provide the necessary 
signal for the cell cycle exit of Sertoli cells, which is the most important criterion for the terminal 
differentiation of these cells. A recent report demonstrated that adult Sertoli cells of mice and 
humans are quiescent and not terminally differentiated in vitro; however, in that study, the 
Sertoli cells were cultured with serum supplementation [134]. Previous studies reported that 
57 
 
serum induced ID proteins in vitro [135] and ID proteins had the potential to reinitiate mitosis in 
terminally differentiated Sertoli cells in vitro [58].  
 Hormonal control of Sertoli cell development plays a crucial role in Sertoli cell 
proliferation and differentiation. Even though the effects of FSH and T3 on Sertoli cell 
development have been well studied, the underlying molecular mechanisms are not fully known. 
Sertoli cells respond to FSH and T3 only during a critical window of their development phase. 
Previous findings showed that Sertoli cell differentiation is an intrinsic timing mechanism and 
they could differentiate in the absence of external signaling factors [26]. Some of the later studies 
showed opposite results, which suggested that Sertoli cell differentiation is not totally an intrinsic 
timing mechanism [131].  
 By selective isolation of Sertoli cells from their in vivo environment it is possible to 
study their direct responses to those hormones. Also, in SC-Cx43 KO mice the indefinite 
proliferation of Sertoli cells raised a critical question related to their response to these hormones 
during pubertal and adult stages at which wt Sertoli cells were unresponsive to these hormones. 
Results from this study showed that SC-Cx43 KO Sertoli cells did not respond to any hormone 
treatments during pubertal or adult stages, similar to those of wt mice. However, 3d to 5d wt 
Sertoli cells responded to those hormones. In contrast, neonatal SC-Cx43 KO Sertoli cells did not 
show any response to both the hormone treatments.  
 There is evidence that CX43 could be a potential T3 target gene in Sertoli cell 
development. CX43 localization or expression levels were modulated as a result of neonatal 
hyper- or hypothyroid conditions [8, 14]. Results from the present study also suggested that in 
the absence of CX43, neonatal Sertoli cells did not respond to T3 treatment. Early studies had 
shown that T3 effects on Sertoli cell differentiation were mediated through CDKIs, p27
Kip1 
and 
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p21
Cip1
 [30, 111]. Also, other studies provided evidence that CX43 regulated p27
Kip1 
and p21
Cip1
 
expressions to control cell proliferation in various cell systems [103, 136]. It is unknown whether 
CX43 regulated p27
Kip1 
and p21
Cip1 
in a similar way in Sertoli cells. Results from this study also 
suggested that SC-Cx43 KO Sertoli cells did not respond to T3 even at neonatal stage because 
CX43 expression might be critical to affect its downstream targets, p27
Kip1 
and p21
Cip1
 to mediate 
the T3 effects on Sertoli cell proliferation. Further studies are needed to investigate the 
interactions of CX43 and these CDKIs in Sertoli cells to affect Sertoli cell proliferation in vitro.  
 Another major endocrine regulator is FSH, which is a potent mitogen of fetal and 
neonatal Sertoli cells. It was shown that cyclin D1 expression mediated the mitogenic response 
of neonatal Sertoli cells to FSH [34]. LI of SC-Cx43 KO Sertoli cells at 20d and 60d was 
significantly higher than that of the age-matched wt mice. Thus, it was possible to speculate that 
SC-Cx43 KO Sertoli cells at pubertal and adult age might respond to FSH treatment in vitro. In 
contrast, results showed that SC-Cx43 KO Sertoli cells were mitogenically unresponsive to FSH 
even at neonatal stage while neonatal wt Sertoli cells responded to FSH. Previous studies showed 
that FSH increased intracellular cAMP levels and in turn resulted in increased Ca
2+
 influx into 
cells [137-139]. Ca
2+ 
plays an important role in Sertoli–Sertoli junction dynamics. Results from 
the present study also support those previous findings that intercellular communication between 
Sertoli cells is essential to mediate the FSH signaling. CX43 being the predominant gap junction 
protein, gap junction formation between adjacent Sertoli cells might be absent in SC-Cx43 KO 
mice. There is evidence that the Cx43 transcript is FSH responsive in some cell systems [94]. 
Further investigations to understand the exact role of CX43 in mediating FSH signaling are 
needed. 
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 In conclusion, isolation and culture procedures for wt and SC-Cx43 KO Sertoli cells were 
successful. The in vitro model was used to study the proliferation pattern of adult SC-Cx43 KO 
Sertoli cells and also to investigate the involvement of CX43 in FSH and T3 signaling in Sertoli 
cells. Results suggested that the Sertoli cell population remained quiescent in the absence of 
CX43 and thus retained the capability to enter cell cycle. Due to the indefinite proliferation of 
SC-Cx43 KO Sertoli cells, they were further tested to determine whether this proliferation might 
affect their response to the endocrine regulators, FSH and T3, which increased proliferation and 
maturation, respectively, in neonatal wt Sertoli cells. Results suggested that CX43 might be 
essential to allow normal responses to FSH and T3 in Sertoli cells. The indefinite proliferation of 
Sertoli cells in SC-Cx43 KO mice showed that their development pattern is altered in these mice, 
compared to wt mice. 
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FIGURES 
 
Figure 7. Cell cycle analysis using flow cytometry. Isolated Sertoli cell fractions from 25 to 40d SC-Cx43 KO mice were stained 
with Hoechst 33342 dye and were measured for DNA content to sort the cells in the different stages of the cell cycle using flow 
cytometry. M1, M2 and M3 refer to cells in G0, S and G2, respectively.  
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Figure 8. Cell smear immunocytochemistry for MKI67 in adult SC-Cx43 KO Sertoli cell fractions sorted by flow cytometry. 
Cell smears were made from cell suspensions of sorted cells in the non-proliferative (G0-A) and proliferative phases (S-B and G2-C) 
of the cell cycle. Cells in G0 (A) were immunonegative for MKI67, whereas cells in S (B) and G2 (C) phases were immunopositive 
for MKI67. Magnification = 200X. 
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Figure 9. Double immunolabelling of adult SC-Cx43 KO Sertoli cells in different phases of the cell cycle, cultured for 4 days in 
serum-free-medium, for GATA4 and MKI67 markers.  
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Figure 9 (cont.). Double immunolabelling of adult SC-Cx43 KO Sertoli cells in different 
phases of the cell cycle, cultured for 4 days in serum-free-medium, for GATA4 and MKI67 
markers. Some cells in G0 fraction (A-C), S (D-F) and G2 (G-I) phases were immnuopositive 
for GATA4 (red; left panel) and MKI67 (green; middle panel) and in the panel of merged images 
(right panel) for GATA4 and MKI67, cells immunopositive for either one or both the markers 
are seen. Note that cells in G0, were immnunonegative for MKI67 at the time of plating.  
However, many cells in G0 fractions (A-C) were immunopositive for MKI67 after 4 days of 
culture. 
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TABLE 1 
 
Group A 
3-5d wt 
Sertoli cell cultures 
Untreated control (control) 
FSH treatment (FSH) 
T3 treatment (T3) 
FSH +T3 treatment (FSH + T3) 
Group B 
20d wt 
Sertoli cell cultures 
Untreated control (control) 
FSH treatment (FSH) 
T3 treatment (T3) 
FSH +T3 treatment (FSH + T3) 
Group C 
5d SC-Cx43 KO 
Sertoli cell cultures 
Untreated control (control) 
FSH treatment (FSH) 
T3 treatment (T3) 
FSH +T3 treatment (FSH + T3) 
Group D 
20d SC-Cx43 KO 
Sertoli cell cultures 
Untreated control (control) 
FSH treatment (FSH) 
T3 treatment (T3) 
FSH +T3 treatment (FSH + T3) 
Group E 
60d SC-Cx43 KO 
Sertoli cell cultures 
Untreated control (control) 
FSH treatment (FSH) 
T3 treatment (T3) 
FSH +T3 treatment (FSH + T3) 
65 
 
 
Figure 10. LI of wt and SC-Cx43 KO Sertoli cells cultured 4 days in serum-free medium. 
Data are expressed as mean ± SEM (except 20d KO (n=5), n=3/group). All groups were 
compared and significant differences were denoted with superscripts. Here, KO refers to SC-
Cx43 KO.
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Figure 11. LI of 5d wt (A) and SC-Cx43 KO (B) Sertoli cells cultured 4 days in serum-free medium without hormones (control) 
or with FSH and/or T3. Treated groups were compared to untreated controls of the same genotype. Data are expressed as mean ± 
SEM and n=3/ group. Values that do not share a common superscript are significantly different. Here, KO refers to SC-Cx43 KO.  
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Figure 12. Double immunolabelling for GATA4 and MKI67 markers in 5d wt and SC-Cx43 KO Sertoli cells cultured 4 days in 
serum-free-medium without hormones (control) or with FSH and/or T3.  
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Figure 12 (cont.). Double immunolabelling for GATA4 and MKI67 markers in 5d wt and 
SC-Cx43 KO Sertoli cells cultured 4 days in serum-free-medium without hormones 
(control) or with FSH and/or T3. Merged pictures of double labeling immnuocytochemistry for 
GATA4 and MKI67 in Sertoli cell cultures of 5d wt and SC-Cx43 KO mice are shown in top (A-
D) and bottom panels (E-H), respectively. Proliferating Sertoli cells were immunopositive for 
both GATA4 (red) and MKI67 (green) in merged pictures. Sertoli cells from wt mice showed 
more proliferation in response to FSH treatment (B) compared to untreated wt controls (A). 
Number of proliferating Sertoli cells in untreated controls were comparable to T3 (C) and 
FSH+T3 (D) treatments in wt. Sertoli cell proliferation in untreated controls of 5d SC-Cx43 KO 
Sertoli cells (E) was comparable to FSH (F), T3 (G) and FSH + T3 (H) treatment groups of the 
same genotype. Magnification = 400X. 
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Figure 13. LI of 20d wt (A), SC-Cx43 KO (B) and 60d SC-Cx43 KO (C) Sertoli cells 
cultured 4 days in serum-free medium without hormones (control) or with FSH and/or T3. 
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Figure 13 (cont.). LI of 20d wt (A), SC-Cx43 KO (B) and 60d SC-Cx43 KO (C) Sertoli cells 
cultured 4 days in serum-free medium without hormones (control) or with FSH and/or T3. 
Each treatment group was compared to controls of the same genotype. Data are expressed as 
mean ± SEM and n=3/ group. There were no significant differences between control and FSH- 
and/or T3-treated groups in both wt and KOs at 20 and 60d time points. KO = SC-Cx43 KO. 
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Figure 14. Double immunolabelling for GATA4 and MKI67 markers in 20d wt, 20 and 60d SC-Cx43 KO Sertoli cells cultured 
4 days in serum-free-medium without hormones (control) or with FSH and/or T3. 
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Figure 14 (cont.). Double immunolabelling for GATA4 and MKI67 markers in 20d wt, 20 
and 60d SC-Cx43 KO Sertoli cells cultured 4 days in serum-free-medium without 
hormones (control) or with FSH and/or T3. Merged pictures of double labeling 
immnuocytochemistry for GATA4 and MKI67 in Sertoli cell cultures of 20d wt (A-D) and SC-
Cx43 KO at 20d (E-H) and 60d (I-L) mice are shown in top, middle and bottom panels, 
respectively. Proliferating Sertoli cells were immunopositive for both GATA4 (red) and MKI67 
(green) in merged pictures. Sertoli cell cultures from wt mice lacked mitotic activity and merged 
pictures were immunopositive only for GATA4 in untreated controls (A) and all hormone treated 
(FSH-B; T3-C and FSH+T3-D) groups. Sertoli cell proliferation in untreated controls of 20d and 
60d SC-Cx43 KO Sertoli cells (E, I, respectively) were comparable to FSH (F, J, respectively), 
T3 (G, K, respectively) and FSH + T3 (H, l, respectively) treatment groups of the same 
genotype. Magnification = 400X. 
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CHAPTER IV 
PROLIFERATION OF SERTOLI CELLS IN THE ABSENCE OF CONNEXIN 43 IS 
PREVENTED BY CONCOMITANT DELETION OF S-PHASE KINASE PROTEIN 
(SKP2) 
 
ABSTRACT 
 Terminal differentiation and cessation of mitogenesis occur by two weeks of age in 
mouse Sertoli cells and they then acquire the capacity to support spermatogenesis. Sertoli cells 
communicate among themselves and with germ cells through gap junctions. In the testis, 
connexin 43 (CX43) is the predominant gap junction protein. Studies from our laboratory, using 
a Sertoli cell-specific Cx43 knockout (SC-Cx43 KO) animal model, have demonstrated that 
CX43 is a key regulator of Sertoli cell development. Approximately 2% of Sertoli cells are 
proliferating in adult SC-Cx43 KO mice. However, the mechanism by which CX43 affects 
Sertoli cell development is not fully understood. SKP2, a ubiquitin-ligase, is highly expressed in 
proliferating cells. Previous literature demonstrated that CX43 suppressed the expression level of 
SKP2 via post-transcriptional mechanisms to inhibit tumor progression. Also, adult Sertoli cell 
number is reduced in Skp2 KO when compared to that of age-matched wildtype (wt) mice. To 
understand whether SKP2 is involved in the extended proliferation of Sertoli cells in the absence 
of CX43, we generated double knockout (DBKO) of Skp2/SC-Cx43 mice. We hypothesized that 
the extended proliferation in SC-Cx43 KO Sertoli cells would be prevented by concomitant 
deletion of Skp2. Our results showed that adult Sertoli cell number in Skp2/SC-Cx43 DBKO 
mice was lower than the SC-Cx43 KO mice due to cessation of Sertoli cell proliferation in 
DBKO mice. Also, the Sertoli cell number in DBKO mice was lower than the wt mice, but 
comparable to the Skp2 KO mice.    
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INTRODUCTION 
 Adult Sertoli cells are terminally differentiated cells. Terminal differentiation of these 
cells is essential for supporting spermatogenesis. Each Sertoli cell supports a fixed number of 
germ cells and is species specific. For example, in rodents each Sertoli cell supports 30-50 germ 
cells [140]. Thus, adult Sertoli cell number is one of the major factors that determine the 
magnitude of spermatogenesis. Even though extensive studies have been done to understand the 
cell cycle of Sertoli cells, it is still not fully understood. It is important to understand the role of 
cell cycle molecules in Sertoli cell development. Some studies have identified the regulatory role 
of certain cell cycle proteins in murine Sertoli cell development using transgenic mouse models 
[53, 111, 141].  
 Protein synthesis and degradation are the two crucial mechanisms used by cells to control 
the concentration of the proteins that are required in each step of the cell cycle. Disruption of 
either of these two mechanisms leads to abnormal cell proliferation and tumerogenesis [142]. 
Protein degradation is mediated mainly by the ubiquitin-proteasome machinery [143]. 
 Skp2,
 
an F-box protein is an essential component of the ubiquitin ligase complex [144]. It 
mainly mediates the ubiqutination and further degradation of p27
Kip1
, a CDKI, the degradation of 
which is essential for the cells to enter the proliferative phase from the quiescent phase [145, 
146]. Obviously, SKP2 has been identified as a protooncogene and is overexpressed in many 
tumors [147]. SKP2 levels are high in S phase during which active DNA replication takes place 
in the cell cycle [148, 149]. In testis, the role of SKP2 was studied using the Skp2 KO animal 
model. These mice showed a marked depletion of germ cells due to reduction in adult Sertoli cell 
numbers.  
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 In seminiferous epithelium, Sertoli cells communicate with each other and with germ 
cells through gap junctions and this communication is essential for coordinated function of 
Sertoli cells in the seminiferous epithelium. CX43 is the predominant testicular gap junction 
protein. We specifically studied the role of CX43 in Sertoli cells and showed that a significant 
population of Sertoli cells maintained indefinite proliferation in the absence of CX43 [150, 151]. 
Extensive studies demonstrated the inhibitory role of CX43 on cell proliferation in many tumors. 
Zhang et al (2003) showed that CX43 suppressed cell proliferation by inhibiting SKP2 post-
translationally in mouse embryo fibroblasts [104]. The regulatory role of CX43 on SKP2 gained 
importance in tumor as well as development studies. However, it is unknown whether CX43 
regulates SKP2 expression in Sertoli cells, which in turn regulate Sertoli cell development. The 
aim of this chapter was to identify whether SKP2 is involved in the CX43 effect on Sertoli cell 
proliferation.  
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MATERIALS AND METHODS 
Generation of Skp2/SC-Cx43 DBKO (DBKO) mice 
 Skp2 global KO and SC-Cx43 KO mice were available in our laboratory. Generation of SC-
Cx43 KO mice was explained in Chapter II. Skp2 KO mice were obtained from Keiko and Keiichi 
Nakayama at Kyushu University, Japan [51]. SC-Cx43 KO female mice are fertile whereas Skp2 
KOs are infertile and SC-Cx43 KO male mice are sterile. SC-Cx43 KO female mice were crossed 
with Skp2 heterozygous male mice to obtain pups heterozygous for Amh-Cre, floxed Cx43, and 
Skp2 in F1 generation. These heterozygous male and female mice were then mated to obtain 
DBKO mice in F2 generation at a ratio of 3 DBKO out of 64 pups. In F3 generation the ratio was 
further narrowed to one DBKO out of six pups by an effective breeding scheme, the details of 
which were shown in figure 15. 
 Mice were housed at 25°C with 12L:12D cycles and given water and a standard rodent 
diet ad libitum. All animal experiments were approved by the IACUC of the University of 
Illinois and conducted in accordance with the National Institutes of Health (NIH) Guide for the 
Care and Use of Laboratory Animals. 
Genotyping 
 Tail genomic DNA was extracted using the DNeasy tissue kit (Qiagen, Valencia, CA) 
according to the manufacturer‟s instructions. PCR was performed using Failsafe PCR system 
(Epicentre Biotechnologies, Madison, WI). PCR products were separated on a 1% agarose gel, 
stained with ethidium bromide, and photographed for documentation. PCR bands at 480 and 520 
kbs denoted Skp2 KO and Skp2 wt alleles, respectively. Genotyping results for SC-Cx43 KO mice 
were analyzed as detailed in Chapter II. The combined results for the Skp2 and the SC-Cx43 
genotyping were used to determine which mice were DBKO's. 
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Experimental groups and time points 
 At 20d and 60d, body and testis weights were measured for wt, SC-Cx43 KO, Skp2 KO and 
DBKO mice (n=4/genotype). Also, for other parameters assessed in this chapter all four genotypes 
were used. 
 Mice were housed at 25°C with 12L:12D cycles and given water and a standard rodent 
diet ad libitum. All animal experiments were approved by the IACUC of the University of 
Illinois and conducted in accordance with the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals. 
Determination of Sertoli cell number  
 In 20d DBKO mice (n=3/genotype), we used sections stained with hematoxylin and eosin 
or WT1 to calculate total Sertoli cell number per testis based on the count of round objects in 
sections of known thickness, using the morphometric methods previously described [119].  
Assessment of Sertoli cell proliferation 
 Serial testes sections were stained for a Sertoli cell marker, WT1 and a cell proliferation 
marker, MKI67 as detailed in chapter II. The percentage of proliferating Sertoli cells was 
determined by MKI67 staining [118] in ~500 Sertoli cells identified
 
by positive WT1 staining per 
testis. 
p27
Kip1 
immunostaining  
 Paraffin embedded testes were sectioned at 4 µm
 
and then deparaffinized and rehydrated. 
Endogenous peroxidase
 
activity was quenched by incubating sections in 0.3% H2O2 for
 
30 min. 
Slides were placed in
 
boiling 10 mM sodium citrate buffer (pH 6.0) for 10 min, then
 
allowed to 
cool to room temperature for antigen retrieval. Immunodetection of p27
Kip1 
protein was performed 
using a murine mononclonal IgG1 to mouse
 
p27
Kip1
 (BD Transduction Laboratories, Lexington, 
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KY). Binding
 
of p27
Kip1 
antibody was localized by using the Vectastain
 
ABC kit (Vector) and 3,3'-
diaminobenzidine
 
substrate kit (Vector) according to the manufacturer‟s instructions. Negative 
control tissue sections were processed with normal
 
goat serum instead of the primary antibody to 
determine nonspecific
 
staining. 
Statistical analysis 
 Data were analyzed with one-way ANOVA and were presented as mean ± SEM. The 
statistical analyses were performed using Prism software (GraphPad Software, Inc., San  
Diego, CA). Differences between groups were considered as statistically significant when p < 
0.05. 
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RESULTS 
 
Body and testis weights of DBKO mice 
 Body and testis weights of DBKO at 20d (figures 16A and C) and 60d (figures 16B and D) 
were compared to wt, SC-Cx43 KO and Skp2 KO of corresponding ages. At 20d, body and testis 
weights of DBKO and Skp2 KO were comparable to each other, but lesser than the weights SC-
Cx43 KO and wt mice. 
 At 20d, in DBKO mice, there were 54% and 66% reductions in body (figure 16A) and 
testis (figure 16C) weights, respectively, when compared to SC-Cx43 KO mice. Also, 20d Skp2 
KO showed 49% and 64% decreases in body and testis weights, respectively, compared to SC-
Cx43 KO mice of corresponding age.  
 At 60d, body weights of DBKO and Skp2 KO were comparable and significantly lower 
than wt and SC-Cx43 KO mice. However, testis weight of DBKO mice was reduced by 71%, 57% 
and 90%, compared to Skp2 KO, SC-Cx43 KO and wt mice, respectively. In addition, Skp2 KO 
testes weighed 48% more than those of SC-Cx43 KO mice (figure 16D). 
Testicular histology of DBKO mice 
 Histology of DBKO (figures 17J-17L) testis sections at various time points were compared 
with wt (figures 17A-17C), SC-Cx43 KO (figures 17D-17F) and Skp2 KO (figures 17G-17I) mice 
of corresponding age. The earliest time point at which DBKO testes were analyzed was 10d (figure 
17J). In the DBKO mice spermatogensis was absent and the seminiferous tubules were 
histologically similar to SC-Cx43 KO mice. Also, in DBKO, as age increased Sertoli cells 
sloughed from the basement membrane and were found inside the tubular lumen whereas, in aged 
Skp2 KO mice, the clusters in the tubular lumen were comprised of mainly germ cells and few 
Sertoli cells. Unlike SC-Cx43 KO and DBKO, complete spermatogenesis was observed in Skp2 
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KO mice. However, some of the seminiferous tubules were devoid of spermatogenesis in Skp2 KO 
mice when compared to wt mice.  
Percent proliferation of Sertoli cells in DBKO mice 
 Sertoli cell proliferation, as determined by LI, was absent in DBKO at both 20d (figure 
18A) and 60d (figure 18B). Proliferating Sertoli cells were positive for WT1 and MKI67 whereas 
non-proliferating Sertoli cells were positive only for WT1 and negative for MKI67. Sertoli cell 
proliferation was absent in DBKO at 20d (figure 19C-19D) and 60d (result not shown) in contrast 
to SC-Cx43 KO mice in which proliferation was observed at both 20d (figure 19A-19B) and 60d 
time points. 
Sertoli cell number in DBKO mice 
 There was a significant reduction in Sertoli cell number of DBKO when compared to SC-
Cx43 KO and wt mice of corresponding age (figure 18C-D). However, Sertoli cell numbers of 
DBKO and Skp2 KO mice were comparable. 
p27
Kip1 
immunostaining in DBKO mice 
 Intensity of p27
Kip1 
immunostaining was lesser in SC-Cx43 KO (figure 20C), compared to 
wt (figure 20A) and Skp2/SC-Cx43 DBKO (figure 20D) testes at 10d. However the intensity of 
p27
Kip1 
in SC-Cx43 KO Sertoli cells was comparable to wt during adulthood (not shown). Also, 
staining intensity of p27
Kip1 
was stronger in Skp2 KO (figure 20B) and Skp2/SC-Cx43 DBKO 
(figure 20D) compared to wt (figure 20A) testes at 10d.  
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DISCUSSION 
 Terminal differentiation of Sertoli cells is a crucial process that makes them capable of 
supporting spermatogenesis. The factors governing the transition of Sertoli cells from 
proliferation to differentiation are not fully elucidated. Thyroid hormone effects on Sertoli cell 
development were demonstrated in rodents [30, 45, 48, 64, 111, 119, 125, 152]. Thyroid 
hormone induced premature differentiation in Sertoli cells [30, 48, 111]. Further studies 
suggested that CX43 localization and/or expression was changed in hypo- or hyper-thyroid 
conditions [8, 14]. Also, induction of differentiation was aberrant in the absence of CX43 in 
other cell types [92, 153] implicating its crucial role in the regulation of proliferation in many 
cell types [104, 105, 154].  
 The mechanism by which CX43 affects Sertoli cell proliferation is not well understood. 
We demonstrated an extended proliferation of Sertoli cells, in vivo and in vitro, beyond the 
normal proliferative period in SC-Cx43 KO mice. A significant percent (approximately 2%) of 
Sertoli cells were proliferating in adult SC-CX43 KO mice, indicating that the proliferation was 
not totally stopped due to the lack of CX43 in Sertoli cells.  
 There are various factors that can affect Sertoli cell development. SKP2 is a ubiquitin 
ligase, which regulates the progression of cells into S phase of the cell cycle. In addition, SKP2 
levels are elevated in tumors. Impaired spermatogenesis was observed in Skp2 KO mice, which 
suggested the integral role of SKP2 in that process [155]. Also, adult Sertoli cell number and 
spermatogenesis were reduced in Skp2 KO mice, compared to that of wt mice. Previous literature 
demonstrated that CX43 suppressed the expression level of SKP2 via posttranslational 
mechanisms to inhibit tumor progression [103, 104].  
 The regulatory roles of CX43 and SKP2 on Sertoli cell development were studied 
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separately. Even though CX43 regulated SKP2 levels in tumors, the regulatory role of CX43 on 
SKP2 levels is not known in Sertoli cells. The increased stability of SKP2 in the absence of 
CX43 might have resulted in prolonged Sertoli cell proliferation and in turn resulted in defective 
differentiation. To test the involvement of SKP2 in the Sertoli cell phenotype of SC-Cx43 KO 
mice, we created a DBKO, which lacks SKP2 globally and CX43 specifically in Sertoli cells. We 
hypothesized that there would be a decrease in the percent of proliferating Sertoli cells and adult 
Sertoli cell number in DBKO when compared to that of age-matched SC-Cx43 KO mice, which 
suggested that SKP2 might be a downstream target of CX43 to affect Sertoli cell proliferation. 
 Body weight and other testicular parameters in DBKO mice were analyzed and compared 
the DBKO with wt, Skp2 KO and SC-Cx43 KO mice. The results showed that the DBKO 
resembled the Skp2 KO at both 20d and 60d in terms of body weight due to the global deletion of 
SKP2 in both Skp2 KO and DBKO mice. Testis weights of DBKO and Skp2 KO mice were 
comparable but significantly reduced when compared to wt and SC-Cx43 KO mice at 20d. At 
60d, Skp2 KO testes weighed 48% more than in SC-Cx43 KO mice due to the arrest of 
spermatogenesis at an early stage in the absence of CX43 in Sertoli cells. Spermatogenesis was 
not absent in Skp2 KO mice, but reduced compared to wt mice. Results showed reduction in 
body and testis weights in Skp2 KO mice when compared to wt mice that corroborated the results 
in a study with Skp2 KO mice [155]. At 60d, testis weights of DBKO mice were reduced by 71% 
compared to age-matched Skp2 KO mice due to absence of spermatogenesis in DBKO, which 
was the effect noticed in the absence of Sertoli cell-CX43 in those mice. However, Sertoli cell 
number in DBKO mice at both the time points (20d and 60d) did not differ significantly from the 
Skp2 KO mice of corresponding age. This indicated that the effect produced in DBKO Sertoli 
cells was predominantly due to the SKP2 deletion.  
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 The results of the present study showed a significant decrease in Sertoli cell number in 
Skp2 KO when compared to wt mice, which was not in concurrence with the study done with 
Skp2 KO mice [155]. The extended proliferation of Sertoli cells in SC-Cx43 KO mice was not 
noticed in DBKO indicating that SKP2 is involved in the CX43 effect of Sertoli cell 
proliferation.   
 SKP2 is a major regulator of p27
Kip1 
concentrations in many cell systems [155]. The 
intensity of p27
Kip1 
immunostaining was stronger in Skp2 KO (figure 20B) and Skp2/SC-Cx43 
DBKO (figure 20D) compared to wt (figure 20A) and SC-Cx43 KO testes at 10d. This suggested 
that p27 accumulation resulted from the absence of SKP2 in both Skp2 KO and Skp2/SC-Cx43 
DBKO mice. This result provided evidence that CX43 in Sertoli cells might reduce the SKP2 
concentrations and that in turn allowed p27
Kip1 
to accumulate in Sertoli cells, which might be 
obligatory for the cessation of proliferation in those cells. The indefinite proliferation of SC-
Cx43 KO Sertoli cells may be the result of lesser accumulation of p27
Kip1
 in those cells. 
 In conclusion, generation of the DBKO mice, which lacked CX43 only in Sertoli cells but 
SKP2 globally, was successful. DBKO mice were compared to wt and both the single KOs (Skp2 
KO and SC-Cx43 KO) to understand the interelationship between Skp2 and Cx43 transcripts in 
Sertoli cell development. Spermatogenesis is absent in SC-Cx43 KO and the DBKO mice. 
However, the DBKO mice resembled Skp2 KO mice in terms of body weight and Sertoli cell 
number. This study again reiterated the absolute importance of CX43 for the progression of 
spermatogenesis, which was shown already in previous studies [9, 13, 156]. The Sertoli cell 
phenotype of incessant proliferation in SC-Cx43 KO mice was reverted due to the concomitant 
deletion of SKP2. This is the first study testing the involvement of a cell cycle regulator in the 
effect of CX43 on Sertoli cell development. Our results showed that SKP2 is involved in the 
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CX43 effects on Sertoli cell proliferation. However, the effects seen in DBKO Sertoli cells might 
have masked those effects due to the absence of CX43. Further mechanistic studies are awaited 
to understand whether CX43 could directly affect the stability of SKP2 expression to stop the 
proliferation of Sertoli cells and which in turn provided a necessary condition for the initiation of 
differentiation in Sertoli cells.  
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FIGURES 
 
 
         Male            Female 
 
Amhwt/wt Cx43wt/wt Skp2wt/-  X   AmhCre/+ Cx43fl/fl Skp2wt/wt 
 
 
 
F1:  
AmhCre/wt Cx43fl/wt Skp2wt/-, AmhCre/wt Cx43fl/wt Skp2wt/wt 
 
AmhCre/wt Cx43fl/wt Skp2wt/-  X  AmhCre/wt Cx43fl/wt Skp2wt/- 
 
 
 
F2:  
AmhCre/wt Cx43fl/fl Skp2-/-  Or AmhCre/Cre Cx43fl/fl Skp2-/-       Skp2/SC-Cx43 DBKO  
 
            
Amhwt/wt Cx43fl/fl Skp2wt/-  X  AmhCre/Cre Cx43fl/fl Skp2wt/- 
Or 
       AmhCre/wt Cx43fl/fl Skp2wt/- 
 
 
 
F3: 
AmhCre/wt Cx43fl/fl Skp2-/- Or AmhCre/Cre Cx43fl/fl Skp2-/-     Skp2/SC-Cx43 DBKO  
 
 
 
Figure 15. Breeding scheme for the generation of Skp2/SC-Cx43 DBKO mice.  
List of mouse genotypes used in the generation of Skp2/SC-Cx43 DBKO mice are as follows: 
SC-Cx43 KO (Amh
Cre/Cre
 Cx43
fl/fl
 Skp2
wt/wt
, Amh
Cre/+
 Cx43
fl/fl
 Skp2
wt/wt
) 
Skp2 het (Amh
wt/wt
 Cx43
wt/wt
 Skp2
wt/-
) 
SC-Cx43 het (Amh
Cre/wt
 Cx43
fl/wt
 Skp2
wt/wt
) 
Het for both SC-Cx43 and Skp2 (Amh
Cre/wt
 Cx43
fl/wt
 Skp2
wt/-
) 
SC-Cx43 KO and Skp2 het (Amh
Cre/Cre
 Cx43
fl/fl
 Skp2
wt/- 
Or   Amh
Cre/wt
 Cx43
fl/fl
 Skp2
wt/-
) 
Cx43 floxed control and Skp2 het (Amh
wt/wt
 Cx43
fl/fl
 Skp2
wt/-
)  
 
3/64 
1/6 
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Figure 16. Body and testis weights of Skp2/SC-Cx43 DBKO (referred here as DBKO) mice.  
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Figure 16 (cont.). Body and testis weights of Skp2/SC-Cx43 DBKO (referred here as 
DBKO) mice. Body weights of DBKO mice were compared to age-matched wt, SC-Cx43 KO, 
Skp2 KO mice at 20d (A) and 60d (B). Body weights of the DBKO (n=4) were significantly 
lower than the wt (n=5) and SC-Cx43 KO (n=5) mice at 20d and 60d (p < 0.001), but 
comparable to the age-matched Skp2 KO mice at both the time-points. Testis weights of DBKO 
mice were comparable to Skp2 KO mice only at 20d (C), whereas significantly lower than the 
other genotypes including Skp2 KO at 60d (D). Values that do not share a common superscript 
are significantly different.  
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Figure 17. Testicular histology of Skp2/SC-Cx43 DBKO mice. 
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Figure 17 (cont.). Testicular histology of Skp2/SC-Cx43 DBKO mice. DBKO testis sections 
were compared to that of wt (A-C), SC-Cx43 KO (D-F) and Skp2 KO (G-I) mice at 10d, 20d and 
60d. Spermatogenesis was absent in the DBKO (J-L) and SC-Cx43 KO mice at all the time 
points. Spermatogenesis was initiated in other genotypes. However, in Skp2 KO testes sections, 
some of the tubules were devoid of spermatogenesis (blue arrows) and spermatogenesis was also 
evident in the same section in a different tubule (black arrows). Also, Skp2 KO mice showed full 
spermatogenesis at 60d (I). Seminiferous tubules of the DBKO mice showed Sertoli cell only 
phenotype at 20d and 60d. Magnification = 400X. 
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Figure 18. Sertoli cell proliferation and number of Skp2/SC-Cx43 DBKO (referred here as DBKO) mice.  
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Figure 18 (cont.). Sertoli cell proliferation and number of Skp2/SC-Cx43 DBKO (referred 
here as DBKO) mice. Sertoli cell proliferation, as determined by labeling index was 
significantly higher for SC-Cx43 KO (n=4) at both 20d (A) and 60d (B), compared to wt (n=4), 
Skp2 KO (n=4) and DBKO (n=4). However, Sertoli cell numbers of DBKO were comparable to 
Skp2 KO at 20d (C) and 60d (D). Values that do not share a common superscript are significantly 
different.  
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Figure 19. Serial section immunostaining for WT1 and MKI67 in the testes sections of SC-Cx43 KO and Skp2/SC-Cx43 DBKO 
mice. 
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Figure 19 (cont.). Serial section immunostaining for WT1 and MKI67 in the testes sections 
of SC-Cx43 KO and Skp2/SC-Cx43 DBKO mice. At 20d, some of the SC-Cx43 KO Sertoli 
cells (white arrows) were immunopositive for both WT1 (A) and MKI67 (B). However, in 
Skp2/SC-Cx43 DBKO testis section, none of the Sertoli cells stained positive for WT1(C) were 
positive for MKI67 (D). Magnification = 400X. 
* Figures 19A and 19B were published before and the citation was given below:  
Role of connexin 43 in Sertoli cells of testis. Sridharan S, Brehm R, Bergmann M, Cooke PS. 
Ann N Y Acad Sci. 2007 Dec;1120:131-43. 
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Figure 20. Immunostaining for p27
Kip1
. 
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Figure 20 (cont.). Immunostaining for p27
Kip1
. p27
Kip1
 immunostaining was compared in the 
testes sections of  wt (A), Skp2 KO (B), SC-Cx43 KO (C), and Skp2/SC-Cx43 DBKO (D) at10d. 
Black arrows show the cells that are immunopositive for p27
Kip1
. The staining intensity was 
weakest in the SC-Cx43 KO sections compared to other genotypes. Staining intensity was 
stronger in the Skp2 KO testes. However, p27
Kip1 
staining of DBKO were comparable to Skp2 
KO testes sections. Magnification = 200X. 
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CHAPTER V 
SERTOLI CELL PROLIFERATION IN ADULT SERTOLI CELL-SPECIFIC 
CONNEXIN 43 KNOCKOUT MICE AFTER CONCOMITANT DELETION OF CELL 
CYCLE REGULATORS, p27
Kip1 
or p21
Cip1 
 
ABSTRACT 
 CX43 regulates Sertoli cell differentiation. The mechanism by which CX43 affects 
Sertoli cells is unclear. Cyclin dependent kinase inhibitors (CDKIs) negatively regulate cell cycle 
progression. p27
Kip1 
and p21
Cip1
 are the major CDKIs in mouse testis. It has been shown that p27 
KO, p21 KO and p27p21 DBKO mice have increased adult Sertoli cell number, which revealed 
the central role of these CDKIs in Sertoli cell development. Previous studies had demonstrated a 
link between CX43 and CDKIs in cell proliferation. CX43 increased p27
Kip1
 expression, by 
suppressing SKP2, to inhibit tumor progression. p21
Cip1
 expression was induced by CX43 
expression in some cell types. It is not known whether the CX43 expression in Sertoli cells also 
regulated p27
Kip1 
and p21
Cip1
 in a similar manner. It is unknown whether CX43 mediates T3 
hormone effects on Sertoli cell proliferation through these CDKIs. To understand whether 
CDKIs are involved in the CX43 effect on Sertoli cell proliferation, we created DBKOs of 
p27/SC-Cx43 and p21/SC-Cx43 mice. We hypothesized that there would be an increase in the 
percent of proliferating Sertoli cells and adult Sertoli cell number in DBKOs of p27/SC-Cx43 
and p21/SC-Cx43 mice when compared to SC-Cx43 KO mice of corresponding age. Our results 
showed that Sertoli cell proliferation was not potentiated in both the types of DBKO mice, 
whereas their Sertoli cell numbers of p27/SC-Cx43 and p21/SC-Cx43 DBKO mice were 
comparable to SC-Cx43 KO as well as p27 KO and p21 KO mice, respectively. Sertoli cell 
numbers in all DBKO and single KO mice were higher than age-matched wt mice. 
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INTRODUCTION 
 Thyroid hormone (T3) is a key regulator of Sertoli cell development. Previous studies 
identified that T3 induced both p27
Kip1 
and p21
Cip1
 in neonatal Sertoli cells in vivo [111] as well as 
in vitro [30], indicating that both these CDKIs are major factors in terminating Sertoli cell 
proliferation. p27
Kip1
 and p21
Cip1
 regulate
 
the G1/S transition of the cell cycle. Also, T3 affected the 
localization and/or expression level of CX43 in Sertoli cells [8, 14]. Thus T3 affected Sertoli cell 
proliferation via p27
Kip1
, p21
Cip1 
and also CX43. CX43 might mediate the T3 effects on Sertoli cell 
development by regulating p27
Kip1 
and p21
Cip1 
levels in Sertoli cells. The link between CX43 and 
CDKIs in Sertoli cell development has not been previously addressed. The potential of CX43 
channels to stimulate p21
Cip1
 was already shown in some cell types [136, 157]. Moreover, CX43 
increased p27
Kip1 
expression, by suppressing SKP2, to inhibit tumor progression [104]. However, it 
is unknown whether CX43 in Sertoli cells also regulates p27
Kip1 
and p21
Cip1 
in a similar manner. 
 The role of CDKIs in testis development was studied using p27 KO, p21 KO and p27p21 
DBKOs. These KOs and DBKO mice had increased adult Sertoli cell number but the Sertoli cell 
proliferation was terminated at the same time as that of wt mice, which indicated that the increased 
Sertoli cell number was due to an increased rate of Sertoli cell proliferation [48, 49]. In SC-Cx43 
KO mice, adult Sertoli cell number was increased when compared to wt mice and the proliferation 
continued even into adulthood, which made the Sertoli cells in this animal model different from 
p27 KO, p21 KO and p27p21 DBKO Sertoli cells.  
 To understand whether p27
Kip1 
and/or p21
Cip1
 are involved in the CX43 effect on Sertoli 
cell proliferation, we created DBKOs of p27/SC-Cx43 and p21/SC-Cx43 mice. The aim of this 
chapter was to study whether CDKIs were involved in the effect of CX43 on Sertoli cell 
proliferation.  
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MATERIALS AND METHODS 
Generation of p27/SC-Cx43 DBKO mice 
 Transgenic mouse lines of p27 KO and SC-Cx43 KO were used. Generation of SC-Cx43 
KO mice was detailed in Chapter II. SC-Cx43 KO female mice were fertile whereas p27 KOs were 
infertile and SC-Cx43 KO male mice are sterile. SC-Cx43 KO female mice were crossed with p27 
heterozygous male mice to obtain pups heterozygous for Amh-Cre, floxed Cx43, and p27 in F1 
generation. These heterozygous male and female mice were then mated to obtain p27/SC-Cx43 
DBKO mice in the F2 generation at a ratio of 3 DBKO mice out of 64 pups. In the F3 generation 
the ratio was further narrowed to one DBKO mouse out of six pups by an effective breeding 
scheme, the details of which were shown in figure 21.  
Generation of p21/SC-Cx43 DBKO mice  
 Male and female p21 KO mice were fertile. Thus, generation of this DBKO was easier 
compared to p27/SC-Cx43 DBKO mice. The breeding scheme in generating the p21/ SC-Cx43 
DBKO was shown in figure 22.  
Experimental groups and time points 
 In this chapter two kinds of DBKO mice were studied and each DBKO mouse model was 
compared with its corresponding single KO and wt mice at two time points (20d and 60d). For 
example, p27/SC-Cx43 DBKO mice were compared with wt, SC-Cx43 KO and p27 KO mice of 
corresponding age for each parameter.  
Animal care  
 Mice were housed at 25°C with 12L:12D cycles and given water and a standard rodent 
diet ad libitum. All animal experiments were approved by the IACUC of the University of 
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Illinois and conducted in accordance with the National Institutes of Health (NIH) Guide for the 
Care and Use of Laboratory Animals. 
Tissue processing for histology and immunostaining  
 Testes were drop-fixed using 10% neutral buffered formalin fixative at 20d but fixed by 
vascular perfusion using the same fixative at 60d. Fixed testes were embedded in paraffin, 
sectioned at 4 μm, and stained with hematoxylin and eosin for histology.   
Assessment of Sertoli cell number and proliferation 
 In p27/SC-Cx43 and p21/SC-Cx43 DBKOs, Sertoli cell number and percent proliferation of 
Sertoli cells were assessed at 20d and 60d (n=3/ genotype/ time-point). Sertoli cell number was 
assessed using morphometric methods based on count of round objects in sections of known 
thickness as previously described [119]. For Sertoli cell number assessment WT1 or hematoxylin 
and eosin stained testicular sections were used.  
 Sertoli cell proliferation of these DBKO mice was assessed by serial section 
immunohistochemistry for WT1 and MKI67 markers that was explained in chapter II. 
Statistical analysis 
 All parameters were analyzed using one-way ANOVA followed by Student-Newman-
Keuls test for multiple comparisons and presented as mean ± SEM. Differences were considered 
significant when p < 0.05.  
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RESULTS 
Body and testis weights of p27/SC-Cx43 DBKO mice  
 At 20d, there was no significant difference in body weights of p27/SC-Cx43 DBKO mice 
when compared to other genotypes (figure 23A). However, testis weights of these DBKO mice 
were decreased by 46% (p < 0.001) and 52% (p < 0.001) compared to wt and p27 KO mice, 
respectively (figure 23C).  
 At 60d, body weights of these DBKO mice (figure 23B) were comparable to p27 KO 
mice but significantly different from wt and SC-Cx43 KO mice (p < 0.01). Body weights showed 
a significant increase in p27 KO at 60d, compared to that of age-matched wt mice, consistent 
with a previous report [49]. However testis weights of DBKO mice (figure 23D) were decreased 
by 81% (p < 0.001) and 70% (p < 0.001) from age-matched p27 KO and wt mice, respectively. 
The testis weights of DBKO mice were comparable to SC-Cx43 KO mice at both time points.  
Body and testis weights of p21/SC-Cx43 DBKO mice 
 There was no significant difference in body weights of p21/SC-Cx43 DBKO mice when 
compared to other genotypes at 20d and 60d (figures 24A-24B). At 20d, the testis weights of 
these DBKO mice were decreased by 53% (p < 0.001) and 57% (p < 0.00) from that of age-
matched wt and p21 KO mice, respectively  (figure 24C). At 60d, testis weights of the DBKO 
mice were reduced by 84%, (p < 0.001) compared to age-matched p21 KO (figure 24D). At 20 d 
and 60d, body weights these DBKO mice did not differ significantly from the age-matched wt 
controls. 
Testicular histology of p27/SC-Cx43 and p21/SC-Cx43 DBKO mice 
 Testicular histology of p27/SC-Cx43 and p21/SC-Cx43 DBKOs was compared to p27 
and p21 KO mice, respectively, at 20d (figures 25A-25B and 25E-25F) and 60d (figure 25C-
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25D, 25G-25H). Spermatogenesis was absent in both DBKOs (figures 25B, 25D, 25F and 25H), 
which was similar to the testicular phenotype of SC-Cx43 KO mice. However, spermatogenesis 
was initiated at 20d in p27 KO (figure 25A) and p21 KO (figure 25E) and they were 
histologically comparable to those of wt mice.  
Percent proliferation of Sertoli cells in p27/SC-Cx43 DBKO mice 
 In SC-Cx43 KO mice a significant percent of proliferative Sertoli cells were noticed at 20d 
(2.2% ± 0.3%) and 60d (1.3% ± 0.1%). However, the Sertoli cell proliferation was almost absent in 
p27 KO (0.05% ± 0.01%) and wt (0.02% ± 0.02%) mice at 20d. Sertoli cell proliferation was 
completely absent at 60d in p27 KO and wt mice. The proportion of proliferative Sertoli cells in 
p27/SC-Cx43 DBKO mice (0.25% ± 0.14%) at 20d (figures 26A) was significantly lower than the 
SC-Cx43 KO mice and absent at 60d (figure 26B), but comparable to p27 KO and and wt mice. 
Sertoli cell proliferation was assessed by serial section IHC for WT1 and MKI67 and proliferating 
Sertoli cells in this DBKO was significantly lower than the age-matched SC-Cx43 KO mice (figure 
28A-28D). 
Percent proliferation of Sertoli cells in p21/SC-Cx43 DBKO mice 
 Percentage of proliferating Sertoli cells in p21/SC-Cx43 DBKO mice at 20d (0.72% ± 
0.14%) and 60d (0.01% ± 0.01%) were significantly lower than that of SC-Cx43 KO mice of 
corresponding age (figures 27A-27B).  However, p21 KO (0.05% ± 0.02% at 20d and absent at 
60d) and wt mice were comparable at both the time points. Serial section IHC for WT1 and MKI67 
to assess Sertoli cell proliferation showed proliferating Sertoli cells in this DBKO even at 60d, but 
significantly lower than SC-Cx43 KO mice (figure 28E-28F). 
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Sertoli cell numbers of p27/SC-Cx43 DBKO mice 
 Sertoli cell numbers of p27/SC-Cx43 DBKO mice (7.15 ± 0.62 x 10
6
) were comparable to 
both p27 KO (7.87 ± 0.52 x 10
6
) and SC-Cx43 KO (6.66 ± 0.98 x 10
6
) mice, but were significantly 
increased compared to wt mice (3.85 ± 0.14 x 10
6
) at 20d (figure 26C). At 60d, there was a 107% 
increase in Sertoli cell number of p27/SC-Cx43 DBKO mice (7.25 ± 0.17 x 10
6
), compared to wt 
mice (3.5 ± 0.37 x 10
6
) of the same age (figure 26D). Also, adult Sertoli cell numbers in p27 KO 
mice (7.68 ± 0.24 x 10
6
) were increased by 119%, compared to age-matched wt mice (3.50 ± 0.37 
x 10
6
) and this was consistent with previous reports [49]. Sertoli cell numbers of SC-Cx43 KO 
mice at 20d (6.66 ± 0.98 x 10
6
, p < 0.05) and 60d (6.06 ± 0.99 x 10
6
, p < 0.05) were significantly 
increased compared to wt mice (3.85 ± 0.14 x 10
6
 and 3.50 ± 0.37 x 10
6
, at 20d and 60d, 
respectively). 
Sertoli cell numbers of p21/SC-Cx43 DBKO mice 
 Sertoli cell numbers of p21/SC-Cx43 DBKO mice (5.04 ± 0.30 x 10
6 
and 5.13 ± 0.51 x 10
6
) 
were comparable to that of p21 KO (5.15 ± 0.45 x 10
6 
and 4.90 ± 0.33 x 10
6
) and SC-Cx43 KO at 
20d and 60d, respectively (figures 27C, 27D, respectively). In contrast, Sertoli cell numbers of 
p21/SC-Cx43 DBKO mice were increased by 68% at 60d compared to age-matched wt mice. 
Sertoli cell numbers of p21 KO were 40% more than that of age matched wt mice, which 
corroborated with previous reports [49]. 
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DISCUSSION 
 Progression through the cell cycle is driven by the association of cyclin dependent 
kinases and their regulatory subunits, cyclins. The activities of the cyclin-CDK complexes are 
modulated by two classes of CDKIs, namely, INK4 CDKIs and „CIP/KIP‟-family of CDKIs. 
p27
Kip1 
and p21
Cip1 
are the functional units of the CIP/KIP-family CDKIs that bind to CDK-
cyclin complexes and inhibit their action, which result in cell cycle arrest [158]. 
 p27
Kip1 
inhibits the activation of cyclin-CDK complexes and thus affects the progression 
of the cell cycle. As a result of p27
Kip1 
overexpression, entry of a cell into S phase is prevented. 
p27
Kip1
 potently inhibits retinoblastoma phosphorylation, which upon hyperphosphorylation 
relieves the block on the E2F family of transcription factors that in turn activate the gene targets 
essential for the progression of cell cycle. p27
Kip1
 transcript levels are similar in proliferating and 
quiescent cells [159]. Nevertheless, cell cycle arrest occurs in p27 KO cells, particularly Sertoli 
cells [49, 160]. These findings suggested that there might be some cell cycle arrest pathways in 
Sertoli cells, which did not involve p27
Kip1 
and p21
Cip1 
to compensate during the absence of those 
CDKIs.  
 p21
Cip1 
was the first CDKI found and was originally identified in human fibroblasts as 
one of the components of cyclin-CDK complex [161, 162]. In vitro and in vivo studies reported 
that the complex of p21
Cip1 
and PCNA (proliferating cell nuclear antigen) can specifically only 
inhibit the proliferative activity, but not the DNA repair activity, of PCNA [161, 163-165].   
 Previous studies showed the localization patterns of p27
Kip1 
and p21
Cip1 
in mouse testis 
during development. Nuclear staining of p27
kip1
 was observed
 
in gonocytes, whereas no staining 
was observed in actively proliferating Sertoli cells from E16.5 to 3d during which gonocytes 
were in quiescent state and Sertoli cells were actively proliferating. However, during E14.5 to 
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2d, occasional p27
kip1
 staining
 
was observed in the cytoplasm of Sertoli cells. In adult mouse and 
human testes, strong nuclear expression of p27
kip1
 was observed in Sertoli cells [53]. Expression 
of p27
kip1
 in adult Sertoli cells is important in regulation
 
of proliferation or apoptosis of 
undifferentiated spermatogonia
 
and the start of meiotic prophase [53]. Expression of p21
Cip1 
was 
noticed only in pachytene spermatocytes and spermatids, but not in spermatogonia.  
 Earlier studies showed an inverse relationship between p27
Kip1 
and p21
Cip1 
expression in 
Sertoli cells and their proliferation [49]. In addition, studies showed that T3 modulated Sertoli 
cell proliferation through effects on p27
Kip1 
and p2
Cip1 
expression [30, 111]. Early studies have 
shown that expression of p27
Kip1 
coincided with terminal differentiation of Sertoli cells [29, 30, 
111]. In SC-Cx43 KO mice, we observed an increase in Sertoli cell population size and also a 
significant population of adult Sertoli cells was proliferating indefinitely. However, the 
mediatory factors involved in the CX43 effects on Sertoli cell proliferation were unknown.  
 CX43 inhibits cell proliferation by increasing the p27
Kip1 
concentrations in many cell 
lines [103] and stimulates p21
Cip1 
expression in many cell types [136, 157]. Recently it has been 
shown that EGF (epidermal growth factor) induced phosphorylation of CX43 (inactive form) and 
reduced the levels of p27
Kip1 
and p21
Cip1 
in mouse embryonic stem cells [166]. The results from 
chapter IV showed that the indefinite proliferation of Sertoli cells in the absence of CX43 was 
stopped after concomitant deletion of SKP2, which is a major regulator of the CDKIs. However, 
p27
Kip1 
staining was weak in wt and SC-Cx43 KO mice at 10d in contrast to that of the age-
matched Skp2 KO and Skp2/SC-Cx43 DBKO mice. This suggested that p27
Kip1 
expression might 
be higher advanced in Skp2 KO and Skp2/SC-Cx43 DBKO mice than in wt and SC-Cx43 KO 
mice. Based on previous results, we hypothesized that CX43 effects on Sertoli cell proliferation 
would involve the CDKIs, p27
Kip1 
and p21
Cip1
.  
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 In order to study the involvement of either p27
Kip1 
or p21
Cip1 
in CX43 effects on Sertoli 
cell proliferation, we generated p27/SC-Cx43 and p21/SC-Cx43 DBKO mice, which globally 
lack p27
Kip1 
and p2
Cip1
, respectively, but specifically lack CX43 only in Sertoli cells. Testis 
weights of both the DBKO mice were comparable to that of SC-Cx43 KO mice because 
spermatogenesis was absent in both the DBKO testes. This result proved that CX43 is 
indispensible for the progression of spermatogenesis as reported previously with the global 
deletion of CX43 [13]. Histological examination of p27/SC-Cx43 and p21/SC-Cx43 DBKO 
testes also showed that Sertoli cells sloughed off from the basement membrane and formed 
clusters inside the tubular lumen as observed in SC-Cx43 KO testes with increasing age. Some 
p27 KO testes displayed focal areas of Sertoli cell-only phenotype in some seminiferous tubules, 
while surrounding tubules were normal in appearance.  
 The regulatory roles of p27
Kip1 
and p21
Cip1 
on Sertoli cell development were studied using 
p27 KO, p21 KO and p27p21 DBKO mice. These KOs and DBKO mice showed a significant 
increase in Sertoli cell population size when compared to wt mice [49, 53]. Sertoli cell numbers 
in DBKOs of p27/SC-Cx43 and p21/SC-Cx43 did not show significant difference from that of 
p27 KO and p21 KO, respectively. Also, Sertoli cell numbers of these DBKOs were comparable 
to that of age-matched SC-Cx43 KO mice. This result showed that the absence of either p27
Kip1 
or p21
Cip1 
along with CX43 did not result in an additive increase in the Sertoli cell numbers of 
both these DBKO mice. This suggested that the signaling pathway by which CX43 and these 
CDKIs affected Sertoli cell proliferation may be redundant.   
 The ultimate size of the Sertoli cell population is a result of their rate and duration of 
proliferation during development minus any apoptosis. In p27 KO and p21 KO mice, Sertoli cell 
proliferation was terminated at the same time as in wt mice, despite increased Sertoli cell 
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numbers in both KO mice. In contrast, a significant population of Sertoli cells in the SC-Cx43 
KO mice proliferated indefinitely into adulthood. We expected to see more proliferating Sertoli 
cells in p27/SC-Cx43 and p21/SC-Cx43 DBKO mice, compared to SC-Cx43 KO mice, due to the 
deletion of both CX43 and one of the CDKIs, p27
Kip1 
and p21
Cip1
, respectively, in these DBKO 
mice.  Once again, the p27/SC-Cx43 and p21/SC-Cx43 DBKO mice, resembled p27 KO and p21 
KO mice, respectively, and did not show any significant increase in the proliferative fraction of 
adult Sertoli cells compared to SC-Cx43 KO mice. This finding again reiterated the possibility 
that these CDKIs might be downstream of CX43.  The extended proliferative phase of Sertoli 
cells in SC-Cx43 KO mice was not seen in either of the DBKO mice. The Sertoli cell 
proliferative pattern of p27/SC-Cx43 and p21/SC-Cx43 DBKO mice might be similar to p27 KO 
and p21 KO mice, respectively, but not SC-Cx43 KO mice. The absence of any additive effect in 
the Sertoli cell proliferation indicated that both CX43 and CDKIs might be the factors involved 
in the same pathway or both act through the same pathway in affecting Sertoli cell proliferation.  
 Earlier studies showed that in mouse embryonic fibroblasts, CX43 increased p27
Kip1 
concentrations by inhibiting SKP2. Also, CX43 modulated p27
Kip1 
concentrations only in the 
presence of SKP2 (Zhang et al, 2003). In the absence of either p27
Kip1 
or p21
Cip1
, the Sertoli cells 
proliferation stops beyond 16d, which is similar to that of p27/SC-Cx43 and p21/SC-Cx43 
DBKO mice. However, it is still unclear how the indefinite proliferation of Sertoli cells noticed 
in SC-Cx43 KO mice was reduced significantly in the absence of either p27
Kip1 
or p21
Cip1
 along 
with CX43. 
 CX43 regulation of SKP2 might be absent in SC-Cx43 KO mice, which in turn resulted 
in prolonged proliferation of Sertoli cells in these mice. However the p27
Kip1 
immuno-
concentrations in adult Sertoli cells were comparable to the age-matched wt mice. It is unknown 
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whether SKP2 concentrations were regulated by other factors that did not involve CX43 in p27 
KO, p21 KO Sertoli cells, but if so that might be a reason for the Sertoli cells in these KO mice 
undergo differentiation at the same time as that of wt mice. Also, the same mechanism might be 
active in the p27/SC-Cx43 and p21/SC-Cx43 DBKO Sertoli cells. There is another possibility 
that there might be some alternative regulatory mechanisms, which did not involve SKP2 and 
CX43, controlling the Sertoli cell division in these DBKO mice, but not in the SC-Cx43 KO 
mice. However, extensive studies suggested that SKP2 regulates cell proliferation mainly by 
inhibiting CDKIs [49, 53, 103, 104]. In the absence of the CDKIs, SKP2 regulation of Sertoli 
cell proliferation might be non-functional.  
 In conclusion, DBKOs of p27/SC-Cx43 and p21/SC-Cx43 mice were generated 
successfully to study the involvement of p27
Kip1 
or p21
Cip1
 in the CX43 effects on Sertoli cell 
development. p27/SC-Cx43 and p21/SC-Cx43 DBKO mice are unique animal models, which 
lack one gene globally and another gene conditionally in Sertoli cells. Body weights of p27/SC-
Cx43 and p21/SC-Cx43 DBKO mice were comparable to p27 KO and p21 KO mice, 
respectively, whereas testis weights of both the DBKO mice were comparable to that of the age-
matched SC-Cx43 KO mice. The roles of CX43, p27
Kip1 
and p21
Cip1 
on Sertoli cell development 
have been studied individually. In other cell systems CX43 regulated these CDKIs, but it is not 
known in Sertoli cells. This is the first study assessing the involvement of CDKIs in the effect of 
CX43 on Sertoli cell development. Results showed that there was no additive effect in the Sertoli 
cell numbers in both the DBKO mice, which suggested the existence of a redundant pathway by 
which CX43 and these CDKIs affect Sertoli cell proliferation. However, p27/SC-Cx43 and 
p21/SC-Cx43 DBKO mice closely mimicked the Sertoli cell development pattern seen in p27 
KO and p21 KO mice, respectively, rather than that of SC-Cx43 KO mice. Further studies are 
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needed to investigate the molecular mechanisms involved in the regulatory role of CX43 on 
CDKIs to affect Sertoli cell development in mice. 
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FIGURES 
 
 
 
 
       Male   Female 
Amhwt/wt Cx43wt/wt p27wt/-  X   AmhCre/+ Cx43fl/fl p27wt/wt 
 
 
F1:  
AmhCre/wt Cx43fl/wt p27wt/-, AmhCre/wt Cx43fl/wt p27wt/wt 
 
AmhCre/wt Cx43fl/wt p27wt/-  X  AmhCre/wt Cx43fl/wt p27wt/- 
 
 
F2:  
AmhCre/wt Cx43fl/fl p27-/-  Or AmhCre/Cre Cx43fl/fl p27-/-          p27/SC-Cx43 DBKO  
 
            
Amhwt/wt Cx43fl/fl p27wt/-  X  AmhCre/Cre Cx43fl/fl p27wt/- 
                                 Or 
                                 AmhCre/wt Cx43fl/fl p27wt/- 
 
 
F3: 
AmhCre/wt Cx43fl/fl p27-/- Or AmhCre/Cre Cx43fl/fl p27-/-      p27/SC-Cx43 DBKO  
 
 
 
Figure 21. Breeding scheme for the generation of p27/SC-Cx43 DBKO mice. 
List of mouse genotypes used in the generation of p27/SC-Cx43 DBKO mice are as follows: 
SC-Cx43 KO (Amh 
Cre/Cre
 Cx43 
fl/fl
 p27 
wt/wt
, Amh 
Cre/+
 Cx43 
fl/fl
 p27 
wt/wt
) 
p27 het (Amh 
wt/wt
 Cx43 
wt/wt
 p27 
wt/-
) 
SC-Cx43 het (Amh 
Cre/wt
 Cx43 
fl/wt
 p27 
wt/wt
) 
Het for both SC-Cx43 and p27 (Amh
Cre/wt
 Cx43 
fl/wt
 p27 
wt/-
) 
SC-Cx43 KO and p27 het (Amh 
Cre/Cre
 Cx43 
fl/fl
 p27 
wt/- 
Or Amh 
Cre/wt
 Cx43 
fl/fl
 p27 
wt/-
) 
Floxed Cx43 and p27 het (Amh 
wt/wt
 Cx43 
fl/fl
 p27 
wt/-
)  
3/64 
1/6 
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Male   Female 
 
Amhwt/wt Cx43wt/wt p21-/-  X   AmhCre/+ Cx43fl/fl p21wt/wt 
 
 
 
F1:     AmhCre/wt Cx43fl/wt p21wt/- 
 
 
AmhCre/wt Cx43fl/wt p21wt/-  X  AmhCre/wt Cx43fl/wt p21wt/- 
 
 
F2:  
AmhCre/wt Cx43fl/fl p21-/- Or AmhCre/Cre Cx43fl/fl p21-/-          p21/SC-Cx43 DBKO  
 
Amhwt/wt Cx43fl/fl p21-/-  X  AmhCre/Cre Cx43fl/fl p21-/- 
                                            Or 
                                AmhCre/wt Cx43fl/fl p21-/- 
 
    
F3:                
AmhCre/wt Cx43fl/fl p21-/- Or AmhCre/Cre Cx43fl/fl p21-/-       p21/SC-Cx43 DBKO  
   
 
 
Figure 22. Breeding scheme for the generation of p21/SC-Cx43 DBKO mice. 
List of mouse genotypes used in the generation of p21/SC-Cx43 DBKO mice are as follows: 
p21 KO (Amh
wt/wt
 Cx43
wt/wt
 p21
-/-
) 
SC-Cx43 KO (Amh
Cre/Cre
 Cx43
fl/fl
 p21
wt/wt
) 
Het for SC-Cx43 and p21 (Amh
Cre/wt
 Cx43
fl/wt
 p21
wt/-
) 
Floxed Cx43 and p21 KO (Amh
wt/wt
 Cx43
fl/fl
 p21
-/-
) 
 
 
 
 
2/3 
3/64 
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Figure 23.  Body and testis weights of p27/SC-Cx43 DBKO (referred here as DBKO1) mice.  
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Figure 23 (cont.). Body and testis weights of p27/SC-Cx43 DBKO (referred here as 
DBKO1) mice. Body weights of DBKO1 mice were compared to age-matched wt, SC-Cx43 
KO, p27 KO mice at 20d (A) and 60d (B). Body weights of DBKO1 (n=3) were significantly 
higher than the wt (n=5) and SC-Cx43 KO (n=5) mice at 60d (p < 0.05), but not at 20d. Also, 
body weights of p27 KO (n=4) mice were significantly higher than the wt and SC-Cx43 KO mice 
at 60d (p < 0.01). Testis weights of DBKO1 mice were comparable to SC-Cx43 KO mice at both 
the time-points. Testis weights of DBKO1 were significantly lower (p < 0.001) than wt and p27 
KO at 20d (C) and 60d (D). Values that share a common superscript are not significantly 
different.  
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Figure 24. Body and testis weights of p21/SC-Cx43 DBKO (referred here as DBKO2) mice.  
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Figure 24 (cont.). Body and testis weights of p21/SC-Cx43 DBKO (referred here as 
DBKO2) mice. Body weights of DBKO2 (n=3) mice were comparable to age-matched wt, SC-
Cx43 KO, p21 KO (n=3) mice at both 20d (A) and 60d (B). Testis weights of DBKO2 mice were 
comparable to SC-Cx43 KO mice at both the time-points. Testis weights of DBKO2 were 
significantly lower (p < 0.001) than wt and p21 KO at 20d (C) and 60d (D). Values that do not 
share a common superscript are significantly different.  
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Figure 25. Testicular histology of p27/SC-Cx43 KO and p21/SC-Cx43 DBKO mice.  
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Figure 25 (cont.). Testicular histology of p27/SC-Cx43 KO and p21/SC-Cx43 DBKO mice. 
Spermatogenesis was absent in both the DBKO mice at both 20d (B and F) and 60d (D and H), 
whereas spermatogenesis was initiated at 20d in p27 KO (A) and p21 KO (E) and also full 
spermatogenesis was observed in the testes sections of p27 KO (C) and p21 KO (G) at 60d. 
Seminiferous tubules of the both the DBKO mice showed Sertoli cell only phenotype at 20d and 
60d. Magnification = 400X (A-D) and 200X (E-H).
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Figure 26. Sertoli cell proliferation and number of p27/SC-Cx43 DBKO (referred here as DBKO1) mice.  
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Figure 26 (cont.). Sertoli cell proliferation and number of p27/SC-Cx43 DBKO (referred 
here as DBKO1) mice. Sertoli cell proliferation, as determined by labeling index was 
significantly higher for SC-Cx43 KO (n=4) at both 20d (A) and 60d (B), compared to wt (n=4), 
p27 KO (n=3) and DBKO1 (n=3). However, Sertoli cell numbers of DBKO1 were comparable to 
SC-Cx43 KO and p27 KO mice at 20d (C) and 60d (D). Values that do not share a common 
superscript are significantly different.  
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Figure 27. Sertoli cell proliferation and number of p21/SC-Cx43 DBKO (referred here as DBKO2) mice.  
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Figure 27 (cont.). Sertoli cell proliferation and number of p21/SC-Cx43 DBKO (referred 
here as DBKO2) mice. Sertoli cell proliferation, as determined by labeling index was 
significantly higher for SC-Cx43 KO (n=4) at both 20d (A) and 60d (B), compared to wt (n=4), 
p21 KO (n=3) and DBKO2 (n=3). Sertoli cell numbers of DBKO2 were comparable to SC-Cx43 
KO and p21 KO mice at 20d (C) and 60d (D). Values that do not share a common superscript are 
significantly different.  
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Figure 28. Serial section immunostaining for WT1 and MKI67 in the testes sections of SC-
Cx43 KO, p27/SC-Cx43 DBKO and p21/SC-Cx43 DBKO mice.   
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Figure 28 (cont.). Serial section immunostaining for WT1 and MKI67 in the testes sections 
of  SC-Cx43 KO (20d), p27/SC-Cx43 DBKO (20d) and  p21/SC-Cx43 DBKO (60d) mice.  
Cells which are immuopositive for both WT1 and MKI67 are proliferating Sertoli cells. Some of 
the Sertoli cells in SC-Cx43 KO and p27/SC-Cx43 DBKO and p21/SC-Cx43 DBKO (white 
arrows) mice were immunopositive for both WT1 (A, C and E, respectively) and MKI67 (B, D 
and F, respectively). However, very few Sertoli cells were proliferating in both the DBKOs, 
compared to SC-Cx43 KO mice. Magnification = 400X. 
* Figures 28A and 28B were published before and the citation was given below:  
Role of connexin 43 in Sertoli cells of testis. Sridharan S, Brehm R, Bergmann M, Cooke PS. 
Ann N Y Acad Sci. 2007 Dec;1120:131-43. 
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CHAPTER VI 
CONCLUSIONS 
 The present studies were conducted to understand the role of CX43 in Sertoli cell 
development. Based on the results of these studies, the following conclusions can be drawn: 
 
1. CX43 is a major regulator of Sertoli cell development in mice and is essential for 
cessation of proliferation and terminal differentiation of Sertoli cells. I generated a Sertoli 
cell-specific Cx43 knockout animal model to study the specific role of CX43 in Sertoli cells. SC-
Cx43 KO mice showed continued Sertoli cell proliferation long after Sertoli cell proliferation 
had ceased in wt mice. As a result of indefinite proliferation of Sertoli cells, Sertoli cell numbers 
were significantly increased in SC-Cx43 KO mice compared to wt mice. However, Sertoli cell 
maturation marker, Tr 1 mRNA, was significantly increased in SC-Cx43 KO, compared to age-
matched wt Sertoli cells. This showed that the maturation of Sertoli cells was impaired in this 
animal model. Results suggested that CX43 plays a key inhibitory role in controlling Sertoli cell 
proliferation and is essential for normal maturation of Sertoli cells in mice. Also, testicular 
histology of this animal model showed absence of spermatogenesis and the seminiferous tubules 
had a Sertoli cell-only phenotype with a few early stage germ cells. Data clearly showed that 
CX43 in Sertoli cells is essential for spermatogenesis but not for maintenance and proliferation 
of spermatogonia.  
 
2. Sertoli cells fail to exit the cell cycle completely in the absence of CX43. A significant 
population of adult Sertoli cells in SC-Cx43 KO mice proliferated in vivo as well as in vitro in 
contrast to the age-matched wt Sertoli cells, which were terminally differentiated. I hypothesized 
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that there was a random population of Sertoli cells entering and exiting the cell cycle in the SC-
Cx43 KO mice. I assessed the pattern of proliferation of Sertoli cells in SC-Cx43 KO mice using 
an in vitro system. Results showed that a significant population of Sertoli cells in the non-
proliferative fraction of SC-Cx43 KO Sertoli cells resumed mitosis in vitro, which indicated that 
the non-proliferative Sertoli cells retained the capacity to proliferate.  In addition, many of the 
cells in the proliferative fraction at the time of plating exited the cell cycle after 3-4d of culture. 
 
3. Sertoli cells did not respond to FSH and T3, which are the major endocrine regulators of 
Sertoli cell development, at any stage during development in vitro. It was unknown whether 
the indefinite proliferative phase in a significant population of SC-Cx43 KO Sertoli cells would 
keep them in their neonatal state. It was also not known whether these Sertoli cells would 
respond mitogenically to FSH due to their indefinite proliferative phase. Cx43 is a target for the 
T3 effects on Sertoli cell development, and it was unknown whether the indefinite in vitro 
proliferation of SC-Cx43 KO Sertoli cells would be stopped by T3 treatment. We hypothesized 
that juvenile and adult SC-Cx43 KO Sertoli cells would respond mitogenically to FSH but not to 
T3 treatment in terms of Sertoli cell proliferation. However, results showed that SC-Cx43 KO 
Sertoli cells were unresponsive to both FSH and T3 at 20 and 60d in contrast to the proposed 
hypothesis. Strikingly, even neonatal SC-Cx43 KO Sertoli cells did not respond to any of these 
hormones. These results suggested that the indefinite proliferation of SC-Cx43 KO Sertoli cells 
even into adulthood might not be due to the maintenance of neonatal state. Also, the Sertoli cell 
proliferation in SC-Cx43 KO mice might be unaltered by any of the classical hormonal signals 
that normally regulate Sertoli cell proliferation. 
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4. The indefinite proliferation of Sertoli cells in the absence of CX43 was prevented by the 
concomitant deletion of Skp2. The regulatory roles of CX43 and SKP2 on Sertoli cell 
development have been studied separately. CX43 inhibited SKP2 levels in tumors, but the 
regulatory role of CX43 on SKP2 levels in Sertoli cells is not known. The increased stability of 
SKP2 in the absence of CX43 might have resulted in prolonged Sertoli cell proliferation and in 
turn resulted in defective differentiation. To test the involvement of SKP2 in the Sertoli cell 
phenotype of SC-Cx43 KO mice, we created a DBKO, which lacks SKP2 globally and CX43 
specifically in Sertoli cells. We hypothesized that there would be a decrease in the percent of 
proliferating Sertoli cells and adult Sertoli cell number in Skp2/SC-Cx43 DBKO when compared 
to that of age-matched SC-Cx43 KO mice, which suggested that SKP2 might be a downstream 
target of CX43 to affect Sertoli cell proliferation. Result showed that the Sertoli cell phenotype 
of ongoing proliferation in SC-Cx43 KO mice was reversed by the concomitant deletion of 
SKP2. This is the first study testing the involvement of a cell cycle regulator in the effect of 
CX43 on Sertoli cell development. Our results showed that SKP2 is involved in CX43 effects on 
Sertoli cell proliferation. SKP2 is the major regulator of p27
Kip1 
levels in many cell types [155]. 
Intensity of p27
Kip1 
immunostaining was stronger in Skp2 KO and Skp2/SC-Cx43 DBKO, 
compared to wt (figure 6A) and SC-Cx43 KO testes at 10d. This suggested that p27
Kip1 
accumulation resulted from the absence of SKP2 in both Skp2 KO and Skp2/SC-Cx43 DBKO 
mice. This result provided evidence that CX43 in Sertoli cells might reduce SKP2 concentrations 
and that in turn allow p27
Kip1 
to accumulate in Sertoli cells, which might be obligatory for the 
cessation of proliferation in those cells. The indefinite proliferation of SC-Cx43 KO Sertoli cells 
may be the result of reduced accumulation of p27
Kip1
 in those cells. 
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5. Proliferation of Sertoli cells in the absence of CX43 involved cyclin dependent kinase 
inhibitors, p27
Kip1 
or p21
Cip1
. The role of CDKIs in testis development was studied using p27 KO, 
p21 KO and p27p21 DBKOs. These KOs and DBKO mice had increased adult Sertoli cell number 
but the Sertoli cell proliferation was terminated at the same time as that of wt mice, which 
indicated that the increased Sertoli cell number was due to an increased rate of Sertoli cell 
proliferation [48, 49]. In SC-Cx43 KO mice, adult Sertoli cell number was increased when 
compared to wt mice and the proliferation continued even into adulthood, which made the Sertoli 
cells in this animal model different from p27 KO, p21 KO and p27p21 DBKO Sertoli cells. The 
link between CX43 and CDKIs in Sertoli cell development has not been previously addressed. The 
potential of CX43 channels to stimulate p21
Cip1
 was already shown in some cell types [136, 157]. 
Moreover, CX43 increased p27
Kip1 
expression, by suppressing SKP2, to inhibit tumor progression 
[104]. However, it is unknown whether CX43 in Sertoli cells also regulates p27
Kip1 
and p21
Cip1 
in a 
similar manner. To understand whether p27
Kip1 
or p21
Cip1
 are involved in the CX43 effect on 
Sertoli cell proliferation, DBKOs of p27/SC-Cx43 and p21/SC-Cx43 mice were created. This is the 
first study assessing the involvement of CDKIs in the effect of CX43 on Sertoli cell development. 
Results showed that there was no additive effect in the Sertoli cell numbers in both the DBKO 
mice, which suggested the existence of a redundant pathway by which CX43 and these CDKIs 
affect Sertoli cell proliferation. However, p27/SC-Cx43 and p21/SC-Cx43 DBKO mice closely 
mimicked the Sertoli cell development pattern seen in p27 KO and p21 KO mice, respectively, 
rather than that of SC-Cx43 KO mice.  
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Figure 29. Schematic diagram showing the expression patterns of CX43 and cell cycle 
regulators in Sertoli cell during development.  CX43 is localized in the cytoplasm of Sertoli 
cells while they are proliferating but it is localized along the plasma membrane of differentiated 
Sertoli cells. Expression of cell cycle regulators like SKP2 and p27
Kip1 
and p21
Cip1 
inside the 
nucleus of Sertoli cells changes with their stage of development. SKP2 concentrations are greater 
in the nucleus of Sertoli cells, which inhibits nuclear accumulation of p27
Kip1
. In differentiated 
Sertoli cells accumulation of p27
Kip1 
and p21
Cip1 
are increased while SKP2 concentrations are 
low.  
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